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This thesis explores the separation and purification of proteins using novel 
conducting electroactive polymers. Polymers such as polypyrrole, polythiophene and 
polyaniline have been widely studied in recent years. The present work focuses on the 
use of polypyrrole (PPy) membranes in model systems designed for the separation of 
certain proteins.
The first system tested involved the incorporation of the selected dyes, Cibacron 
Blue and Blue Dextran, into PPy membranes. The composite membranes formed were 
characterised by x-ray photoelectron spectrometry (XPS), cyclic voltammetry and 
scanning electron microscopy. In preliminary experiments, the behaviour of two 
model proteins, bovine serum albumin (BSA) and ovalbumin (OVA), in 
chromatography on Cibacron Blue-agarose was evaluated. It was shown that BSA 
bound to the support and was eluted with a high salt buffer while OVA was not 
retained by the support. However, this behaviour was not duplicated on the dye- 
containing PPy membranes. Using radiolabelled proteins it was found that both BSA 
and OVA bound to PPy/dye membranes with OVA binding being greatest. Both 
proteins also bound to a control membrane in which p-toluene sulfonate replaced the
111
dye molecule. Pre-treatment with a solution of the protein, casein, reduced this 
apparent non-specific binding, but did not eliminate it.
A second system was evaluated in an attempt to exploit the binding of heparin 
with the proteolytic enzymes, trypsin and thrombin. Heparin was readily incorporated 
into PPy membranes as shown by XPS and chemical assay. The resulting membranes 
bound both trypsin and thrombin and these enzymes were released by high salt buffers. 
Some evidence was also obtained for electrochemically driven binding and release of 
trypsin.
Enzymatic modification of heparin, after incorporation into PPy, was carried out 
in an attempt to enhance the effect of changes to the charge on the membrane. This 
would be expected to increase the release of bound enzymes under electrochemical 
control. It was found that heparinase-modified PPy/heparin membranes had reduced 
thrombin binding capacity. As an alternative to heparin in these experiments, the 
polyanion poly (2-methoxyaniline-5-sulfonate) was investigated in composite PPy 
membranes. These membranes were found to bind thrombin tightly but the bound 
thrombin was not released in high salt buffers
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Chapter 1 Introduction 1
CHAPTER 1 INTRODUCTION
In this thesis, the study of membranes with sulfonated organic molecules (dyes) 
or heparin incorporated into conducting electroactive polymers is reported. The 
biological and electrochemical properties have been investigated particularly with 
respect for protein separations.
1.1 CONDUCTING POLYMERS
Matter can be classified according to electrical conductivity into four classes: 
insulators, semi-conductors, conductors and superconductors. Until the 1960s, 
polymers had been used as insulators. It was not until 1977 when A. G. MacDiarmid 
and A. J. Heeger from the University of Pennsylvania, in cooperation with Prof. H. 
Shirakawa, from Tokyo Institute of Technology, found that the conductivity of 
polyacetylene, at room temperature, can be increased by ca. 12 orders of magnitude 
after doping with iodine. In other words, polyacetylene can be changed from an 
insulating form with conductivity about 10*9 S/cm before doping to the conducting 
form with conductivity more than 102 S/cm after doping [1-3]. The traditional concept
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that all polymers are insulators was proven to be incorrect. Conducting polymers have 
since been widely studied [4-9].
Conducting electroactive polymers such as polypyrroie, polythiophene and 
poiyaniline have been a major focus of scientific research in recent years. Their 
chemical structures are shown in Figure 1.1
polypyrroie poiythiophene
Figure 1.1 Chemical structure o f some conducting polymers. Where A  is the anion 
incorporated during polymer formation; n is usually between 2 and 4.
Among conducting polymers, polypyrroie is particularly attractive since it is 
stable and is easily prepared. It is one of the most extensively studied conducting 
polymers over the past two decades [10].
1.1.1 Formation of Polypyrroie Films
Polypyrroie (PPy) can be formed by either chemical or electrochemical 
oxidation. In comparison with chemical polymerisation, electrochemical 
polymerisation offers some unique advantages. One advantage is that the process of 
doping can be quantitatively controlled [10]. Polymerisation of pyrrole by
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electrochemical oxidation is the main method used for preparation of polypyrroie films 
[11,12]. The polymerisation is believed to proceed via a reactive 71-radical cation [13­
15], which reacts with neighbouring pyrrole species to produce a chain that is 
predominantly a ,a  -  coupled (at 2 and 5 positions). As a result, the resulting polymer 
has a positive charge and incorporates anions from the supporting electrolyte as 
counterions. These are known as dopants [16-18], A schematic representation of the 
overall process is shown in Figure 1.2. The process of polymerisation occurs according 
to the reaction shown in Equation 1.1.
Figure 1.2 The overall process o f polypyrrole formation, n refers to stoichiometric 
ratio o f the polymer units to counterions [18].
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(1.1)
Equation 1,1 A' is the anion incorporated during polymer formation, n is usually 
between 2 and 4.
1.1.2 Origin of Conductivity in Poiypyrrole
In order for a polymeric system to be conductive, it must possess not only charge 
carriers but also an orbital system in which the charge carriers are free to move, 
therefore allowing it to carry a current. This is similar to metals that have free 
movement of electrons through the structure. In the case of semi-conductors both 
electron and defects are charge carriers. For poiypyrrole the charge carriers are known 
as polarons and bipolarons (Figure 1.3) [19-21].
It is noted that poiypyrrole possesses a highly conjugated 7i-electron carbon 
skeleton. The conduction process in this conjugated system is believed to occur via 71- 
electron delocalization along the polymer chain [10,22], A polaron (radical cation) is 
formed as one electron is removed during oxidation. With further oxidation, a second 
electron could be removed from the polymer backbone and a bipolaron is formed. 
These polarons and bipolarons move along the conjugated backbone by the 
rearrangement of the double bonds and single bonds. As a result, polarons and 
bipolarons behave as the charge carriers and thus contribute to conduction. When
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reduction occurs, the loss of poiarons and bipolarons results in the conductivity of the 











Figure 1.3 The main charge carriers in the conducting electroactive polypyrrole.
The process of poiarons and bipolarons introduced into the polylyrrole chain is 
known as doping, which can be an oxidation or reduction of the polypyrrole backbone, 
p-doping is achieved by partial oxidation (removal of electrons) by electron-acceptors, 
while n-doping is a partial reduction (additional of electrons) by electron-donors. 
Thus, defects are introduced along the polypyrrole backbone and then may act as 
charge carriers.
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In order to maintain the charge balance, dopant ions are associated with the 
polypyrrole skeleton. Doping can be reversible, on dedoping the associated ions are 
expelled in response to a change in charge of the poiypyrrole backbone.
1.1.3 Properties of Poiypyrrole Films
Poiypyrroies are electroactive and the oxidation/reduction process may result in 
the movement of anions in and out of the polymer according to the reaction shown in 
Equation 1.2. This mechanism results in some interesting differences in properties 










Equation 1.2 A  is the anion incorporated during polymer oxidation/reduction.
If the anion is small and mobile, the insertion of anions into the polymer is 
usually reversible with expulsion of anions occuring at negative potentials. However, 
it has been found that the doping and dedoping processes are not as simple as shown in 
Equation 1.2. For example, some large polyanions are entangled during their
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incorporation in the polymer and therefore, do not move in and out of the polymer 
matrix upon oxidation-reduction of conducting polymers such as polypyrrole [10]. 
Studies using the Electrochemical Quartz Crystal Microbalance (EQCM) have shown 
that both anions and cations may be incorporated/expelled as the potential is cycled 
[23,24]. As a result, cations can be incorporated into the polypyrrole structure to 
contribute to charge compensation when the polymer is reduced and anion movement 
is not fast enough. The process occurs according to the reaction shown in Equation 
1.3.
Equation 1.3 JT is the cation incorporated during polymer oxidation/reduction.
These mechanisms have been applied in numerous practical technologies such as 
bioseparations [25-28], biosensing [29,30] and biomaterials [31,32],
The practical use of polypyrrole has become particularly attractive as it can be 
eiectrochemically polymerised at relatively low potential from aqueous solution at 
neutral pH. Other conducting polymers are more limited in this respect. For example, 
polyaniline is formed by polymerisation of aniline at low pH, while thiophene is only 
soluble in organic solvents [10,25],
A wide range of counterions can be incorporated into polypyrrole. Examples 
include, simple anions [33,34], proteins such as enzymes, antibodies [35-37] and DNA
Chapter 1 Introduction 8
[38,39]. Even more complex molecular systems have been used as counterions 
including, for example, red blood cells [31]. Sulphonated dyes can be incorporated 
into conducting polymers as the counterion to induce interactions with particular 
proteins [40]. Poly electrolytes such as Dextran sulfate, Chondroitin sulfate and 
heparin [25, 41-44] have also been used in forming polypyrrole films.
1.2 PROTEIN SEPARATION
The separation and purification of proteins is key to many areas of biochemical 
research, such as in enzymology, hormone research and immunology [45]. It is also 
very important in the food industry, for example, enzymes are produced by Novo and 
Sturge for degrading starch into glucose and maltose [46]. To meet the need for 
increased efficiency in production of commercially valuable proteins and the 
associated stringent quality criteria, efficient protein separation techniques have long 
been developed and these are discussed below.
Knowledge of at least some of the chemical and physical properties of the 
proteins will aid the design of a purification process. Methods for separation of 
proteins take advantage of properties such as charge, size and solubility, properties that 
vary from one protein to the next. Since many proteins bind to other biomolecules, 
proteins can also be separated on the basis of their binding properties [47],
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1.2.1 Protein Purification by Chromatography
Protein purification by chromatography is perhaps the most generally useful 
separation technique [46,47], Techniques that are used include ion-exchange 
chromatography, gel chromatography, hydrophobic chromatography and affinity 
chromatography.
Ion-exchange chromatography is a very efficient method for separating proteins. 
This technique primarily exploits differences in the sign and magnitude of the net 
electric charge of proteins at a given pH. The chromatographic column consists of a 
long tube filled with particles of a synthetic resin containing fixed charged groups. 
Proteins bind to ion-exchangers by electrostatic forces between the protein’s surface 
charges (mainly) and dense clusters of charged groups on the exchangers. A protein 
must displace the counter-ions and become attached. The separation is achieved by 
gradually changing the ionic strength and/or the pH of the solution being passed 
through the column.
Gel chromatography, also called size-exclusion chromatography, takes 
advantage of differences in size. The column contains a cross-linked polymer with 
pores of selective size. Larger proteins migrate faster than smaller ones, because they 
are too large to enter the pores in the beads and hence take a more direct route through 
the column. The smaller proteins enter the pores and are slowed by the longer path 
they take through the column.
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Hydrophobic chromatography provides an additional means of protein 
separation. The surface hydrophobic amino acids of the protein are usually arranged in 
patches, interspersed with more hydrophilic domains. The number, size and 
distribution of these non-ionic regions is a characteristic of each protein and can 
therefore be used as a basis for their separation. In hydrophobic chromatography, the 
interacting non-ionic group is provided by a hydrophobic functionality attached to an 
inert matrix such as agarose in a column. Protein adsorption is induced at high salt 
concentration. Most successful protein purifications from hydrophobic columns have 
used decreasing salt gradients.
Affinity chromatography is the most powerful approach to highly selective 
protein separation and purification [46,48-50]. Proteins carry out their biological 
function through one or more binding activities and therefore contain a binding site for 
the interaction with other biomolecules. Unlike all other methods of protein 
separation, which rely on differences in the physical and chemical properties of 
proteins of interest in a mixture, affinity chromatography is based on recognition 
between biologically active materials. The mechanism of affinity chromatography is 
shown in Figure 1.4. One of these materials, the ligands, is usually covalently coupled 
to an inert support, and has the ability to specifically recognise the target protein and to 
bind it reversibly.





Figure 1.4 Schematic representation of affinity chromatography.
Normally, to carry out affinity chromatography the following process needs to 
be undertaken. Firstly an appropriate ligand needs to be chosen, and immobilised onto 
a support matrix. Following this, the protein mixture to be separated is loaded onto the 
column packed with this affinity adsorbent. The final steps are to remove the non­
specifically bound proteins by washing and then specifically elute the target protein by 
step-wise or gradient elution with change of pH, ionic strength, or addition of free 
ligand to be added. Simple in concept, affinity chromatography is very successful in 
practice. Dye affinity chromatography and heparin affinity chromatography have been 
widely studied for the separation and purification of various proteins [51-54],
1.2.2 Protein Purification by Affinity Electrophoresis
In addition to chromatography, another important set of methods is available for 
the separation of proteins, based on the migration of charged proteins in an electric 
field, a process called “electrophoresis” [47], Proteins are normally charged in 
aqueous solution due to the ionisation of the acidic and basic amino acid residues of 
the protein.
3 0009 03254506 8
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However, at a certain pH, a protein is present with no net electric charge. This 
characteristic pH is called the isoelectric point, designated pi. Protein has a net 
negative charge at any pH above its pi and will thus move toward the positive 
electrode (the anode) when placed in an electric field. At any pH below this, protein 
has a net positive charge and will move toward the negative electrode, the cathode. 
The farther the pH of a protein solution is from its pi, the greater the net electric charge 
on the protein. This information has practical importance. For a solution containing a 
mixture of proteins, they can be separated on the basis of the direction and relative rate 
of their migration when placed in an electric field at a known pH.
Affinity electrophoresis has also been applied for protein separations [55,56], 
The principle of affinity electrophoresis is that sample proteins are electrophoresed in a 
gel containing immobilized ligands (the “affinity gel”) which interact with the 
protein(s) of interest so retarding the protein(s) compared to their mobility in a control
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gel. Affinity electrophoresis is essentially analogous to affinity chromatography, 
since both methods are based on separation of proteins due to their affinity towards a 
ligand immobilised on a solid-phase carrier. Blue Dextran has been used for affinity 
electrophoresis of proteins interacting with this dye [57],
The protein purification systems described above have been used to successfully 
purify many proteins. However, they are subject to certain limitations. Thus the 
separations based on charge and size are low resolution techniques while affinity 
chromatography uses expensive matrixes often prepared with toxic agents such as 
cyanogen bromide [45], New techniques based on the electrochemical manipulation of 
novel conducting polymers might accordingly prove to be useful additions to the array 
of protein purification methodologies.
1.2.3 Dyes/ Poiypyrrole System
Commercially available textile dyes have long been used in protein separation 
[58-60]. It was originally observed that certain kinases bound to Blue Dextran during 
gel filtration [61,62]. This aroused considerable interest in the interaction of the 
chromophore, Cibacron Blue F3GA with various enzymes [59,63,64]. This is a 
negatively charged dye, and so can act as a weak cation exchanger. The structure of 
Cibacron Blue F3GA is shown in Figure 1.5.
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Figure 1.5 The structure o f Cibacron Blue F3GA. Ring A is the anthraquinone ring; 
ring B is the bridging diaminobenzene sulphonate ring; ring C is the triazine ring; and 
ring D is the terminal ring. The molecular formula o f Cibacron Blue F3GA is 
C29TI20CIN7O11S3.
Blue Dextran is Cibacron Blue bound to a soluble dextran preparation. Dextran 
is a soluble polysaccharide derived from glucose. It represents a mixture of molecules 
varying in molecular weight from 10 ~ 300 million. The structure of Blue Dextran is 
shown in Figure 1.6. Dextran can be separated or degraded chemically to yield 
fractions of desired uniform molecular dimensions. Cross-linked dextran has been 
widely used as a gel filtration media. Blue Dextran is commonly used to measure the 
void volume of size-exclusion chromatographic columns.
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Figure 1. ô The structure o f Biue Dextran. The moiecular formula of Blue Dextran 
is C29H20N701283+(CftinOÿn-
Dyes such as Cibacron Blue F3GA have been termed “pseudo-ligands” or 
“biomimetic ligands” in that they generally do not have an obvious structural 
relationship to biological ligands. The use of such dyes in affinity chromatography has 
become popular because they are inexpensive, readily available and extremely stable 
in biological and chemical properties [65,66], Dyes have been immobilised on various 
materials in the search for effective affinity matrices for the purification of a wide 
variety of proteins [53,58,63,67-72], Cibacron Blue F3GA has particular specificity 
towards purine nucleotide-binding enzymes. Though it also binds many other proteins. 
Ring A and ring B (in Figure 1.5) are proposed to make significant contributions to the 
binding of proteins to Cibacron Blue F3GA [73]. The study of chromatographic 
behaviour of different plasma proteins on immobilised Cibacron Blue F3GA showed 
that plasma albumin would specifically bind to the dye. Purification of albumin can be 
accomplished by affinity chromatography on agarose-linked Cibacron Blue F3GA 
[74,75], Furthermore, a range of over 60 dye-ligands have been examined for their
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suitability as protein adsorbents, and it was found that as well as covering a range of 
general protein-binding ability, there was considerable selectivity towards particular 
proteins [73],
Previous investigations have shown that sulfonated aromatics are easily 
incorporated into conducting polymer matrices [10,76,77], As the benzene ring 
becomes an integral part of the resultant polymers, they are not only electroactive and 
conductive but also have very stable mechanical properties [10,20], Similarly 
sulfonated dyes have also been successfully incorporated into conducting polymers 
[40], Dyes/PPy system provides a convenient way to immobilise affinity ligands onto 
the support matrices without the need for chemical cross-linking. Based on Equations
1.2 and 1.3 discussed above, anions and cations are associated or dissociated from the 
polypyrrole matrix during the redox processes. It is expected that the binding and 
release of target proteins from PPy/Dye membranes can be manipulated 
electrochemically to constitute a novel technique for protein purification.
1.2.4 Heparin/PPy System
Heparin is well known as an anticoagulant [54,78], It is a linear, highly sulfated, 
negatively charged glucosaminoglycan, with an average molecular weight of 10,000 ~ 
15,000. It is composed of repeat units of disaccharide (Figure 1.7). It contains 
sulfated D-glucosamin residues and uronic acid. Due to its high surface charge, it can 
function as a high-capacity cation exchanger, and is also known to interact strongly 
with the complex, multifunctional serine proteinase, thrombin [78,79].




Figure 1.7 The major disaccharide unit in heparin
Thrombin plays a key role both in blood coagulation and in other physiological 
processes. It has been observed that thrombin is effective in stopping bleeding on local 
wounds, and has no side-effects [80]. As a result, its application has been expanding 
gradually. Purification of thrombin is very important for medical and clinical 
applications.
A refined study of the structure of thrombin found that there are two anion­
binding exosites in thrombin, which form the presumed heparin binding site, resulting 
in strong binding of heparin to thrombin (Figure 1.8) [81-85].
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Figure 1.8 Proposed mechanism for binding heparin to the anion-binding exosites o f 
thrombin.
Heparin-Sephadex affinity chromatography has been used for thrombin 
purification over many years [54,86-90], As explained in the above introduction, 
sulfonated groups are readily incorporated into the polypyrroie structure. Polypyrrole 
membranes incorporating heparin have been prepared [41-44], The affinity and 
electrochemical separation of thrombin with such novel PPy/heparin membranes will 
also be investigated.
From the above discussion, it seems clear that novel polypyrrole membranes can 
have a number of functions. It could have the properties of ion exchange or other 
attributes from the incorporated counterions. So it has the possibilities of combining 
the ideas of ion exchange chromatography and affinity chromatography into the 
application of this novel material.
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In this thesis, polypyrrole composites containing sulfonated dyes or heparin have 
been evaluated for the affinity separation of a number of target proteins. The binding 
and release of these proteins under electrochemical control was investigated. The 
behaviour of these polypyrrole membranes in binding and release of proteins is studied 
and a comparison made with the behaviour of conventional affinity matrices with the 
same proteins. Throughout this work, the physico-chemical and electrical properties of 
these novel conducting polymers were characterised. In Chapter 2, the experimental 
techniques used throughout this work are described, while Chapter 3 provides details 
on investigations into the use of PPy/Dye systems for protein separation. In Chapter 4, 
the PPy/heparin system for protein separation was investigated. Chapter 5 introduces 
the modification of PPy/heparin with heparinase, sulfatase and by reduction and their 
effects on thrombin binding and release. The final chapter deals with preliminary 
experiments using the system PPy/poly(2-methoxyaniline-5-sulfonic acid) 
(PPy/PMAS) polymer composites.
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CHAPTER 2 EXPERIMENTAL TECHNIQUES
In the present chapter, experimental details are described for all the physical, 
electrochemical and biochemical techniques used throughout the thesis.
2.1 PREPARATION OF METALLISED MEMBRANES
Sputter coating equipment (Figure 2.1) was used for the preparation of 
metallised membranes. In this thesis, the Javac sputtering system was employed, and 
the power source was from Spellman SL 1200. A DC current: 100 mA, 500 Volt was 
employed throughout. Polyvinylidene fluoride (PVDF) membranes (type HVHP), 
obtained from Millipore, with a nominal pore size of 0.22 pm, were used as substrate 
membranes. All PVDF membranes were cut into circles with a diameter of 65 mm 
prior to being coated. The PVDF membranes were sputter coated with platinum (Pt) 
on both sides. The distance between the platinum target and the sample was 120 mm. 
The coating chamber was evacuated to a pressure of 6 x 10"5 mBar and then filled with 
argon; the argon pressure was maintained at 5 x 10'4 mBar during the entire coating 
process. Each membrane was coated for 10 minutes using a constant current of 75 
mA. This resulted in platinum coating thickness within the range of 65 nm to 75 nm.
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To prevent short-circuits the edge of the coated membrane was trimmed before further 
use.
Figure 2.1 Sputter coating equipment.
2.2 PREPARATION OF CONDUCTING POLYMER
Electropolymerisation was the main method used throughout this research to 
prepare conducting polymers. The polymerisation process is represented in Equation 
1.1. Polypyrrole can be formed by oxidation of pyrrole at a suitable anode. In this 
work, two types of substrate were used for electrochemical deposition of polymer. 
They were: platinised PVDF membrane and Reticulated Vitreous Carbon (RVC).
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2.2.1 Preparation of Conducting Polymer on Platinised PVDF Membrane
The conducting polymer can be electrodeposited onto the platinised substrate 
using an appropriate cell (Figure 2.2 (a)). Polymerisation was carried out using a 
three-electrode system in an aqueous electrolyte. The electrolyte was mixed well and 
deoxygenated with nitrogen for about 20 minutes prior to growing the membrane. The 
polymerisation was controlled galvanostatically or potentiostatically by using the 
Model 2049 POTENTIO ST AT-GALV ANO ST AT (AMEL). The schematic diagram 
of the resultant PPy/Pt/PVDF/Pt membrane is also shown in Figure 2.2.(b). The 
diameter of the area electrochemically coated was 4.5 cm. The polymer composite 
membrane was removed from the growing cell after polymerisation, and washed with 
distilled water. It was then incubated in 50% ethanol for 15 minutes to remove 
monomer and the loosely deposited oligomers. Following this, it was rinsed with 
distilled water thoroughly before being air dried.






Figure 2.2 (a) Electrochemical growing cell (100 ml). The platinised side o f the PVDF 
substrate served as the working electrode (WE). Platinum gauze was used as the 
counter electrode (CE) and the Ag/AgCl (3 M  NaCl) was employed as the reference 
electrode (RE).
(b) Schematic diagram o f the PPy/Pt/PVDF/Pt membrane structure.
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2.2.2 Preparation of Conducting Polymer on Reticulated Vitreous Carbon 
(RVC)
RVC is a highly porous substrate, with a high surface area. The polymerisation 
was carried out in a three-electrode cell (Figure 2.3). The RVC substrate was cut into 
portions with varying lengths with 5 mm x 5 mm cross section. Before polymer 
synthesis, the RVC portion was cleaned by soaking in absolute ethanol for 5 minutes, 
rinsed thoroughly with distilled water, and then ultrasonicated in distilled water for 2 
minutes. After that, the RVC was used as the working electrode. 20 mm of the RVC 
was immersed in the polymerisation solution. Polymer deposition was achieved 
electrochemically using similar procedures as those for deposition on the platinum 
substrate (Section 2.2.1).
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WE
Figure 2.3 Three-electrode cell (25 ml) used for polymerisation on the RVC substrate. 
The RVC served as the working electrode (WE). Annulus RVC was used as the counter 
electrode (CE) and a Ag/AgCl (3 M  NaCl) was employed as the reference electrode 
(RE).
2.3 SEPARATION OF PROTEINS USING THE ELECTROCHEMICAL 
METHOD
A transport cell (Figure 2.4) was used to investigate electrochemically controlled 
transport of proteins. Two types of transport cell were used in this work. One was a 
15 ml transport cell; the volume of each chamber was 15 ml. The membrane/solution 
contact area was 3.14 cm2, and contact with each side of the membrane was achieved 
using a sheet of carbon foil. The other cell enabled use of 60 ml solution volumes. The 
membrane/solution contact area was 5 cm2, and contact with each side of the
Chapter 2 Experimental Techniques 26
membrane was achieved with stainless steel. A PPy composite membrane 
(PPy/membrane) was placed in the middle of the cell between the feed solution and the 
receiving solution. During transport experiments, the polypyrrole composite 




Figure 2.4 Diagram o f the transport cell (a); the top view o f PPy/Pt/PVDF/Pt 
membrane (b). The PPy deposited side o f the PVDF substrate served as working 
electrode (WE). The platinised side o f the PVDF substrate was used as the counter 
electrode (CE) and the Ag/AgCl (3 M  NaCl) was employed as the reference electrode
(RE).
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2.4 X-RAY PHOTOELECTRON SPECTROSCOPY (XPS)
XPS is a useful surface analysis technique [91-94] capable of detecting elements 
in the surface region (within 10 nm depth) of films. An XPS spectrum shows binding 
energy versus the intensity of electrons emitted and this enables the distribution of the 
elements present to be determined. In this thesis, XPS analyses of PPy/dye, 
PPy/heparin, PPy/PMAS, and other PPy membranes was carried out by the Division of 
Molecular Science, CSIRO, Clayton.
2.5 SCANNING ELECTRON MICROSCOPY (SEM)
The scanning electron micrographs were obtained using a JSM-T20, scanning 
electron microscope (JEOL TECHNICS). SEM was used to characterise the surface 
morphology of the membrane. Membranes were cut into 0.5 cm x 0.5 cm squares and 
then glued to a sample holder. As the PPy composite membrane was conductive, it did 
not need a gold coating as required for insulating samples.
2.6 CYCLIC VOLTAMMETRY (CV)
Cyclic Voltammetry is one of the most common techniques used to elucidate the 
nature of redox switching processes and to provide insights into electron transfer 
reactions [95-97], Cyclic Voltammetry is an extension of linear sweep voltammetry 
with the voltage scan reversed after the current maximum (peak) of the reduction
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process has been passed. The voltage is scanned negatively beyond the peak and then 
reversed as a linear positive sweep. One or more potential cycles can be performed, 
hence the term “cyclic” voltammetry. Figure 2.5 illustrates the shape of a typical 
cyclic voltammogram.
One of the important parameters that can be obtained from the voltammogram is 
the peak potential Ep, at which the current reaches a maximum value. The other 
important parameter is the peak current ip. One method for measuring ip involves 
extrapolation of a baseline current. For measurement of the peak current for the anodic 
process (ipa), the extrapolated baseline going from the foot of the cathodic wave to the 
extension of this cathodic current beyond the peak must be used as a reference, as 
illustrated by Figure 2.5.
s¿ ¿pQ
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Figure 2.5 Schematic representation o f a typical cyclic voltammogram with an 
electrode o f fixed area. Scan rate was 0.1 V s'1; ipc shows the peak cathodic current, 
ipa shows the peak anodic current. At Epa or E pc the current reaches a maximum value.
The cyclic voltammetric experiments performed throughout this thesis were 
carried out using a conventional potentiostat Model 0152 (Utah Electronics), with the 
Triangular Wave Sweep Generator, Model 0151, and an X-Y recorder. The three 
electrode assembly consisted of a 0.018 cm2 platinum disk working electrode (WE) 
(from BAS), either with or without conducting polymer films deposited, a platinum 
wire counter electrode (CE) and a Ag/AgCl (3 M NaCl) reference electrode (RE)
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(Figure 2.6). Prior to each electrochemical measurement, the platinum disk was 
ground and polished to a flat mirror surface using the polishing kit PK-3 (BAS). It 
was first polished with diamond powder slurry in the order 15 pm, 3 pm and 1 pm 
using a nylon disk wet with distilled water. Then it was polished on a microcloth disk 
with the polishing alumina slurry. After polishing, the electrode was rinsed with 
copious amounts of distilled water and then cleaned by ultrasonication in distilled 
water for 2 minutes.
WE (Pt disk)
Figure 2.6 Diagram o f electrochemical cell (15 ml) used for cyclic voltammetry
experiments.
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2.7 FAST PROTEIN LIQUID CHROMATOGRAPHY (FPLC)
Affinity chromatography was carried out on an FPLC (Pharmacia). Fractions 
were collected using the fraction collector, FRAC-100, and the protein concentration 
measured using a UV-1 monitor at 280 nm. A linear salt gradient (from 0.0 to 1.0 M 
NaCl) in the buffer was applied.
2.8 SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS (SDS-PAGE)
An electrophoretic method commonly used for estimation of purity and 
molecular weight of proteins makes use of sodium dodecyl sulphate (SDS) (Figure 
2.7), an anionic detergent.
O
+ II
Na+ ‘O— S —O— (CH2 )n CH3 
O
Figure 2.7 Chemical structure o f SDS.
SDS binds to most proteins in amounts roughly proportional to the molecular 
weight of the protein, about one molecule of SDS for every two amino acid residues. 
The bound SDS contributes a large net negative charge, so that the intrinsic charge of 
the protein becomes insignificant. In addition, the native conformation of a protein is 
altered when SDS is bound, and most proteins assume a similar shape, and thus a 
similar ratio of charge to mass. Electrophoresis of proteins is generally carried out in
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gels made up of cross-linked polyacrylamide. The polyacrylamide gel acts as a 
molecular sieve, so that the migration of proteins in the gel is approximately inversely 
proportional to their molecular weight. In SDS-PAGE, the SDS-polypeptide 
complexes are negatively charged over a wide range of pH. After electrophoresis, the 
proteins are visualized using a dye such as Coomassie Blue. SDS-PAGE permits the 
quick estimation of the number of proteins in a mixture or the degree of purity of a 
particular protein preparation and has become an almost mandatory analytical 
procedure for determining the molecular weight of proteins.
SDS-polyacrylamide gels were prepared and run according to the method of 
Laemmli [98,99]. Stock solution “L” for the separating gel was 1.5 M Tris and 0.4% 
SDS and titrated to pH 8.8 with HC1. Stock solution “M” for the stacking gel was 0.5 
M Tris and 0.4% SDS and titrated to pH 6.8-7.0 with HC1. Acrylamide stock solution 
‘TSP5 was 30% acrylamide and 0.8% N,N -bis-methyleneacrylamide. Sample buffer 
was 0.0625 M Tris, 2% SDS, 10% glycercol with 0.001% bromophenol blue as the 
dye. The pH of the buffer was titrated to 6.8-7.0 with HC1. The running buffer 
contained 0.025 M Tris, 0.1% SDS, 0.192 M glycine and pH 8.3. Stain solution was 
0.1% Coomassie Blue G 250 in 30% methanol and 10% glacial acetic acid. The 
destain solution was 5% methanol and 10% glacial acetic acid.
10% SDS-PAGE has been used throughout this work. It was carried out on a 
BioRad vertical slab apparatus (Figure 2.8). Separating gels containing 10% 
acrylamide and the stacking gels (4.5%) were prepared according to Table 2.1. The 
gels were chemically polymerised using TEMED and ammonium persulphate.
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Table 2.1 The component o f 10% SDS-PAGE.
% polyacrylamide gel Separating gel Stacking gel
6.3 ml “L” 3.8 ml “L”
8.4 ml “N” 2.3 ml “N”
10% 10.4 ml H20 9.0 ml H20
10 (il TEMED 10 111 TEMED
20 mg Ammonium 
persulphate
20 mg Ammonium 
persulphate
Notes. TEMED—N,N,N',N'-tetramethylethylenediamine.
Figure 2.8 Vertical slab apparatus for SDS-PAGE (BioRad).
Different samples were loaded in the slots at the top of the 10% SDS-PAGE gel. 
The proteins moved into the gel when an electric field was applied. In this work, 10% 
SDS-PAGE was carriedout using a constant potential of 100 V for 1 hour, and then at 
200 V until the dye reached the bottom of the gel. The protein was stained for 1 hour 
and destained over three hours. After that, the position of an unknown protein can be
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compared with the positions to which proteins of known molecular weight migrate in 








Soybean trypsin inhibitor 
Lysozyme
Figure 2.9 The diagram o f 10% SDS-PAGE with stained Coomassie Blue. The 
unknown protein is estimated according to the molecular weight standards.
2.9 125I RADIOLABELLING
To detect the amount of protein binding and release with PPy/dye membranes, 
radio-iodination of certain proteins was carried out using the Iodogen method 
[100,101], 10 pi of 0.25 M phosphate buffer, pH 7.5, 2 pi Na125I, i.e. 0.5-2 mCi, and 
10 pi of BSA or OVA solution (1 mg/ml in 0.05 M phosphate buffer, pH 7.5) were 
added to the iodination reaction tubes which contained 40 pg Iodogen (Pierce). The 
reaction was allowed to proceed for 10 minutes in an ice bath, after which the reaction
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mixture was diluted by the addition of 200 pi of 0.05M phosphate buffer pH 7.5, and 
aspirated from the reaction tube for 15 minutes. Following this the labelled BSA or 
OVA was desalted and purified by chromatography using a 10 ml column of Sephadex 
G-25. 0.05 M phosphate buffer was used to elute the labelled proteins, fractions were 
collected manually by counting drops, 10 drops per tube. Radioiodine was detected 
and quantitated by counting using the MINIAXI y 5000 series gamma counter 
(Packard). An aliquot of 5 pi or 10 pi of each fraction was removed for gamma 
counting. The fractions in the peak were collected as the labelled protein for further 
experiment.
2.10 AUTORADIOGRAPHY
Autoradiography is used to visualize and quantitate radioactive molecules 
hybridized to filters (e.g. Southern, northern, western blots), electrophoresed through 
agarose or polyacrylamide gels, or chromatographed through paper or thin-layer plates 
[102], In this work, to analyse labelled proteins by electrophoresis on 10% SDS- 
PAGE, autoradiography was carried out. The autoradiography allowed the 
visualisation of radioactive proteins after 10% SDS-PAGE and provided a permanent 
record of the 10% SDS-PAGE results.
The autoradiographic procedure was according to the method from published 
papers [103] using Kodak X-OMAT film. The film was placed in close contact with 
the dried radioactive gel in a light-proof cassette. The cassette was stored at -70 °C 
for the duration of the exposure in order to slow the reversion of activated silver
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bromide crystals to the stable form [104], After warming to room temperature, the 
film was developed by standard procedures.
2.11 HEPARIN ASSAY
The heparin content in solution and immobilized on the PPy membranes was 
carried out using the Toluidine Blue (TB) assay [105,106], The metachromatic dye, 
Toluidine Blue, has long been used to determine the amount of heparin 
colorimetrically. This method involved detecting the dye removed from the 
supernatant by adsorption onto the sulfate groups of heparin. The colorimetric 
determination of heparin was carried out as follows: 0.005% Toluidine Blue solution 
was made up in 0.2% NaCl and 0.01 M HC1. In order to assay heparin in solution, 1 
ml TB solution was added into the aliquot of heparin solution. This was then diluted 
with 0.2% NaCl to a total volume of 2 ml and vortex mixed for 10 seconds. 2 ml n- 
Hexane was added and vortex mixed for about 30 seconds until the TB-heparin 
complex, which was red-violet in colour, partitioned into the hexane layer. Following 
this, the aqueous layer was carefully removed and extracted by hexane (2 ml) again. 1 
ml of the aqueous layer was taken off and diluted to 1:10 with absolute ethanol and the 
absorption measured at 631 nm. Assaying heparin on PPy membranes: PPy 
membranes were cut into small squares and incubated in 1 ml TB solution and 1 ml 
0.2% NaCl for 1 hr. 400 pi of supernatant was then taken off and diluted to 1:10 with 
ethanol. The absorbance was then measured at 631 nm. The decrease in the 
absorbance showed the heparin content. In these experiments, 0.2% NaCl served as
blank for UV-spectrum.
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2.12 TRYPSIN ASSAY
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Scheme 2.1 Hydrolysis o f BAPA by trypsin.
Figure 2.10 shows the absorption spectra of DL-BAPA and p-nitroaniline [108], 
The BAPA maximum absorbance is at 315 nm, with no absorbance over 400 nm. p- 
nitroaniline has maximum absorbance at 380 nm. Trypsin activity can be detected by
measuring the absorbance at 410 nm.
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WAVE LENGTH nyj
Figure 2.10 Absorption spectra o f DL-BAPA andp-nitroaniline, both at 10'4M  in 0.05
Mbarbital buffer, pH 8.2 [108].
2.13 THROMBIN ASSAY
To detect the amount of thrombin, the thrombin specific substrate, N-p-tosyl- 
gly-pro-arg-p-nitroanilide was used [109,110], This substrate was hydrolyzed by 
thrombin and the product of p-nitroaniline was measured by absorbance at 410 nm as 





(Abs at 410 nm)
Scheme 2.2 Hydrolysis o f N-p-tosyl-gly-pro-arg-p-nitroanilide by thrombin.
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In this work, the thrombin substrate was obtained from Sigma (T-1637). A 1 
mM stock solution was made up by dissolving 5 mg substrate in 7.55 ml water which 
had been adjusted to pH 4.0 with hydrochloric acid. Thrombin assay solution was 
prepared by diluting the stock solution into 0.05 M Tris buffer, pH 8.2 containing 0.02 
M CaCk. Thrombin activity on membranes was detected by incubating the 
membranes in 30 pM or 20 pM of thrombin substrate solution for a certain duration, 
then adding 20% acetic acid to stop the reaction, and measuring the absorbance at 410 
nm.
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CHAPTER 3 THE POLYPYRROLE/DYE SYSTEM
3.1 INTRODUCTION
A system comprising a sulfonated polyaromatic dye incorporated into 
polypyrrole was investigated and findings are reported in this chapter. Preparation and 
characterisation of these polypyrrole composite membranes is reported in detail. The 
125I radiolabelling technique was used to study protein binding and release using these 
membranes with and without electrochemical control. A comparative study was 
carried out using affinity separations with the traditional dye-substituted beaded resin.
3.2 EXPERIMENTAL
3.2.1 Chemicals and Materials
All reagents were analytical grade unless otherwise stated. Pyrrole obtained 
from Merck was distilled, degassed with argon and stored below -18°C before use. 
Bovine Serum Albumin (BSA), Mwt: 66000, pi: 5.3; ovalbumin (OVA), Mwt: 44000, 
pi: 4.6; myoglobin (MYO), Mwt: 18000, pi: 7.0; Lysozyme (LYS), were all obtained 
from Sigma and used without further purification. Cibacron Blue 3GA (CB) was from
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Sigma. Blue Dextran (BD) supplied by Pharmacia was used in the synthesis of 
polypyrrole composite membranes. Na125I was obtained from Amersham. Iodogen 
was supplied by Pierce and used as directed by the manufacturer. All aqueous 
solutions were prepared with Milli-Q water (18 MQ cm)
Cibacron Blue 3GA covalently coupled with cross-linked agarose gel (Affi-gel 
Blue) was provided by Sigma, C-1285, Type 3000. Sepharose 4B was obtained from 
Pharmacia. Pharmacia PD-10 columns were used to purify I labelled proteins.
Millipore polyvinylidene fluoride (PVDF) membrane (type GVHP) with a 
nominal pore size of 0.22 pm and sputter coated with platinum on both sides, and 
Reticulated Vitreous Carbon (RVC) from ERG were chosen as substrates. The 
preparation of the PVDF substrate membranes sputter coated with platinum has been 
described in Section 2.1.
3.2.2 Preparation of Polypyrrole Composite Membranes
3.2.2.1 Conducting polymer grown on platinised PVDF substrate
Polypyrrole composite membranes were electrochemically synthesised as 
described in Section 2.2.1. For the preparation of membranes with differing levels of 
incorporated dye, the concentration of Cibacron Blue 3GA or Blue Dextran was varied 
during the preparation of membranes. In parallel, other counterions, such as C l, CIO4 
and pTS (p-toluene sulphonic acid) were also incorporated. The different types of 
polypyrrole composite membranes prepared are shown in Table 3.1.
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Table 3.1 Different PPy composite membranes prepared under different polymerisation 
conditions.
PPy composite Polymerisation conditions
membranes
5000 ppm BD + 0.5 M Py, constant 0.5 mA cm-2, 4 minutes
2000 ppm BD + 0.5 M Py, constant 0.5 mA cm*2, 4 minutes
1000 ppm BD + 0.5 M Py, constant 0.5 mA cm*2, 4 minutes
1000 ppm BD + 0.5 M Py, constant 1 mA cm*2, 4 minutes
PPy/BD 1000 ppm BD + 0.5 M Py, constant 0.5 mA cm*2, 8 minutes
(BD: Blue Dextran) 500 ppm BD + 0.5 M Py, constant 0.25 mA cm*2, 5 minutes
500 ppm BD + 0.5 M Py, constant 0.026 mA cm4, 120 minutes
2000 ppm BD + 0.5 M Py, constant 1 mA cm'2, 2 minutes
2000 ppm BD +0.5 M Py, constant 0.026 mA cm'2, 120 minutes
PPy/CB 100 ppm CB + 0.5 M Py, constant 1 mA cm"2, 4 minutes
(CB: Cibacron 
Blue 3 G A)
100 ppm CB + 0.5 M Py, constant 1 mA cm'", 2 minutes
PPy/Cl 0.3 M NaCl + 0.1 M Py, constant 1 mA cm'2, 4 minutes
0.3 M NaCl + 0.1 M Py, constant 1 mA cm'", 2 minutes
PPy/Cl04 0.5 M NaC104 + 0.5 M Py, constant 1 mA cm*z, 4 minutes
0.05 M pTSNa + 0.2 M Py, constant 1 mA cm*', 4 minutes
PPy/pTS 
(pTS: p-toluene
0.05 M pTSNa + 0.2 M Py, constant 1 mA cm*', 2 minutes
sulfonic acid) 0.05 M pTSNa + 0.2 M Py, constant 1 mA cm*',
------ -----------------:----------- ----- 5 ;; 7» 7
1 minute
Notes. The area o f PPy composite membrane was 16 cm2. Py: Pyrrole.
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3.2.2.2 Conducting polymer grown on RVC
The polymerisation was carried out galvanostatically at a particular current 
density for a period of time according to the procedure described in Section 2.2.2. 
Three different types of polypyrrole-RVC materials were made. These were:
1. Polypyrrole-pTS on RVC which was prepared from a solution containing 0.2 M 
pyrrole and 0.05 M pTSNa.
2. Polypyrrole-CB on RVC which was prepared from an aqueous solution 
containing 0.5 M pyrrole monomer and 100 ppm Cibacron Blue 3GA.
3. Polypyrrole-BD on RVC which was prepared from 1 M pyrrole and 2500 ppm 
Blue Dextran or 0.5 M pyrrole with 1000 ppm Blue Dextran.
3.2.2.3 Conducting polymer grown on stainless steel (SS)
A stainless steel wire, 1 mm in diameter, was used. It was cut into 4 cm lengths, 
and cleaned ultrasonically before use. The polymerization solution was deoxygenated 
with nitrogen for 10 minutes before being poured into the 5 ml two-electrode cell. 
Stainless steel, immersed 2 cm into the polymerisation solution, was the anode and 
served as the working electrode, RVC was used as the counter electrode. PPy/BD/SS 
was synthesized in a solution of 1000 ppm Blue Dextran and 0.5 M pyrrole using a 
constant current of 8mA applied for 120 minutes. PPy/pTS/SS was grown in 0.05 M 
pTSNa with 0.2 M pyrrole using a constant current of 8mA supplied for 30 minutes.
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3.2.3 Scanning Electron Microscopy (SEM)
SEM was used for surface morphology studies of the PPy membranes. The 
procedure was carried out as detailed in Section 2.5.
3.2.4 Cyclic Voltammetry (CV)
Cyclic voltammetry has been described in Section 2.6. It was carried out in a 
three electrode electrochemical cell consisting of a Pt disk working electrode, Pt wire 
counter electrode and a Ag/AgCl (3 M NaCl) reference electrode. The PPy was 
electrochemically deposited on the working electrode before cyclic voltammetry. The 
electropolymerisation conditions were the same as those used to produce membranes 
on Pt/PVDF/Pt or RVC with the current density of 0.5 mA cm'2, and a time of 4 
minutes.
3.2.5 X-ray Photoelectron Spectroscopy (XPS)
Polypyrrole composite membranes grown on Pt/PVDF/Pt were characterised by 
XPS as described in Section 2.4. To avoid contamination from air, each PPy 
membrane was cut into a square, 0.5 cm x 0.5 cm, and kept in a closed Petri-dish. The 
elements, C, O, N, S, or Cl on the PPy membrane surface were detected and 
quantitated. The mole ratio of pyrrole/dye was calculated using the Equation (3.1), 
which is derived using the molecular formula of Cibacron Blue, C29H20CIN7O11S3, 
Blue Dextran, Cz^oN vO nSs+^H nO eK , and pyrrole, C4H5N.
Chapter 3 The Polypyrrole/dye system 45
N% - S% x
Py/dye (mole ratio) = --------------—
S% x -i- ..... (3.1)
3.2.6 Protein Separation Using Affinity Chromatograpy
A comparative study was carried out using FPLC with a column of Cibacron 
Blue F3GA-agarose. The Cibracron Blue F3GA-agarose gel was packed in a micro­
column of dimensions 1.0 cm (diameter) x 1.5 cm (length), and equilibrated with 10 
mM Tris-HCl buffer, pH 7.5. A bacteriocide, 0.02% sodium azide, was added into the 
chromatography buffer. 100 pi of a 5 mg/ml protein solution (BSA/OVA/Lysozyme/ 
Myoglobin) was applied to the Blue F3GA column. The column was then washed for 
about 25—30 minutes with Tris-HCl buffer at a flow rate of 0.5 ml/minute until there 
was no protein absorbance detected in the column effluent. Then a linear salt gradient 
from 0.0 to 1.0 M NaCl in the Tris-HCl buffer was applied to effect elution. This was 
followed by an additional wash with 1.0 M NaCl in Tris-HCl buffer pH 7.5. The 
column was re-equilibrated with Tris-HCl buffer, pH 7.5.
3.2.7 Protein Transport Study
The electrochemical transport cell and the experimental procedure employed 
were similar to that described in Section 2.3. The 15 ml transport cell was used in this 
work and protein transport was quantitated using 1 I-labelled proteins. Constant 
current control or constant potential control was employed in this study.
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3.2.8 Protein Assay
Protein concentration was detected by measurement of absorbance at 280 nm. 
I-labelled protein was measured by gamma counting. Proteins were identified by 
SDS-PAGE using a 10% polyacrylamide gel. 125I labelled protein on the 10% SDS- 
PAGE gel was detected by autoradiography.
3.3 RESULTS AND DISCUSSION
3.3.1 Membrane Synthesis and Preliminary Characterisation
3.3.1.1 Membrane synthesis on Pt/PVDF/Pt substrate
Polypyrrole composite membranes were deposited electrochemically according 
to Equation 1.1. XPS data were obtained (see Table 3.2) to show that sulfonated dye, 
either Cibacron Blue or Blue Dextran was incorporated during polymerisation.
Chapter 3 The Polypyrrole/dye system 47
Table 3.2 XPS data for polypyrrole membranes prepared using different counterions 
under various polymerisation conditions.
(a) PPy/BD
Polymerisation conditions C O N S Py/BD
BD Py Current Period atom ic atom ic atom ic a tom ic m ole ra tio
density cone. % cone. % cone. % cone. %
(rnA c m 2) (m in u te )
5000 ppm 0.5 M 0.5 4 59.00 39.33 0.26 0.41 2.22
2000 ppm 0.5 M 0.5 4 59.32 38.13 2.07 0.48 5.94
1000 ppm 0.5 M 0.5 4 60.48 36.36 2.87 0.29 11.64
2000 ppm 0.5 M 1.0 2 59.36 38.05 2.28 0.32 14.37
1000 ppm 0.5 M 1.0 4 61.54 35.62 2.44 0.39 11.77
1000 ppm 0.5 M 0.5 8 60.87 36.76 1.99 0.38 8.71
500 ppm 0.5 M 0.25 5 59.94 37.60 2.07 0.40 8.55
500 ppm 0.5 M 0.013 120 61.73 36.80 1.15 0.32 3.78
2000 ppm 0.5 M 0.013 120 60.10 38.83 0.80 0.27 1.89
(b) PPy/CB
Polymerisation conditions C O N S Py/CB
CB Py Current Period atom ic atom ic atom ic atom ic m ole ra tio
density
cone. % cone. % cone. % cone. %
(m A  cm '2) (m in u te )
100 ppm 0.5 M 0.5 4 73.04 12.25 12.84 1.87 13.06
100 ppm 0.5 M 0.5 2 73.87 12.54 11.78 1.81 12.50
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(c) PPy/pTS
Polymerisation conditions C O N S Py/pTS
pTSNa Py Current Period atom ic a tom ic atom ic atom ic m ole  ra tio
density con e. % cone. % cone. % cone. %
(m A  c m 2) (m in u te )
0.05 M 0.2 M 0.5 4 72.94 14.51 11.06 1.49 7.42
0.05 M 0.2 M 0.5 2 74.91 14.71 9.82 0.56 17.54
0.05 M 0.2 M 0.5 1 73.56 15.33 9.18 1.93 4.76
--------------1------------- 1------------------1--------------- «--------- 2“
Notes. The area ofPPy membrane was 16 cm .
From the XPS results, it was found that the amount of dye incorporated increased 
with increasing dye concentration in the polymerisation solution and with decreasing 
current density employed during polymerisation. The effect of polymer synthesis 
conditions is shown in Figure 3.1. Higher current density may have resulted in 
overoxidation, thus leading to a lower incorporation of the dye.
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(a)
(b)
Figure 3.1(a) The effect of the concentration of Blue Dextran in the 0.5 M  pyrrole 
monomer solution on the BD/Py ratio. Electrochemical polymerisation was carried out 
using current density o f 0.5 mA cm 2 for 4 minutes.
Figure 3.1(b) The effect of the current employed during electrochemical 
polymerisation on the BD/Py ratio.
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Scanning electron micrographs of a platinised PVDF membrane and a PPy/BD 
membrane are shown in Figure 3.2. It is obvious that the formation of PPy/BD has a 
dramatic effect on the surface morphology. It shows the cauliflower-like morphology, 
previously reported for some PPy membranes [10,111], that leads to a greatly increased 
surface area with good potential for high protein binding.
Note from the micrography that the porosity is similar for the PPy/BD membrane 
as for the platinised PVDF membrane.
Figure 3.2 SEM of (a) platinised PVDF membrane and (b) PPy/BD membrane. The 
PPy/BD membrane was formed from an aqueous solution containing 2000 ppm Blue 
Dextran and 0.5 M pyrrole with a constant current density of 0.5 mA cm applied for 4
minutes.
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3.3.1.2 Membrane synthesis on RVC substrate
PPy membranes grown on Pt/PVDF/Pt covered the entire electrode surface (see 
Figure 2.4). However, when the membranes were grown with RVC as substrate, only 
the outer surface of the RVC cube was covered; this was observed when the cube was 
sliced after electropolymerisation. This was found even with extended growing time up 
to 4 hrs or when the RVC was penetrated with monomer by vortex mixing for 2 
minutes and then overnight incubation. A schematic depicting the electrodeposition 






Figure 3.3 Schematic diagram of PPy electrodeposited on RVC substrate.
3.3.1.3 Cyclic voltammetry
Cyclic voltammograms obtained using polypyrroles deposited on platinum disk 
electrodes in several supporting electrolytes were used to study the redox behaviour of 
the films. It was confirmed that the resulting PPy/dye membranes (PPy/BD and 
PPy/CB) were electroactive (Figure 3.4), as they show characteristic peaks for 
oxidation and reduction of the polypyrrole.
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Potential (Volts) vs Ag/Ag/Cl
(a)
(b)
Figure 3.4 (a) Cyclic voltammogram o f PPy/BD in 0.1 MNaCl. Potential applied: + 
0.4 V~ -0.9 V vsAg/AgCl. Scan rate: 50 mV s'.
Figure 3.4 (b) Cyclic voltammogram o f PPy/CB in 0.05 Mphosphate buffer pH 7.5. 
Potential applied: + 0.6 V — 0.8 Vvs Ag/AgCl. Scan rate: 100 mVs .
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3.3.2 Protein Separation Using Affinity Chromatography
The elution profiles for chromatography of BAS and OVA are shown in Figure 
3.4. SDS-PAGE analysis of fractions from Figure 3.4 (b) is shown in Figure 3.5. For 
BSA (Figure 3.4 (a)) it can be seen that most of the protein bound to the column and 
was released by the salt gradient while for OVA the protein was not bound to the 
column. Chromatography of MYO and LYZ showed that each of these proteins also 
bound to the column (data not shown) and were released by salt.
BSA and OVA were chosen as model proteins for further study because their iso­
electric points were similar (5.3 and 4.6 respectively) and this would minimise potential 
differences due to the charge on the proteins.
Chapter 3 Polypyrrole/dye system 54
(a)
(b)
Figure 3.4 The elution profile for chromatography o f (a) BSA and (b) OVA on a 
Cibacron Blue F3GA- agarose column. The chromatographic experiments were run at 
room temperature. The adsorbance at X = 280 nm o f the column effluent was 
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Figure 3.5 SDS-PAGE on 10% polyacrylamide gel o f fractions eluted during 
chromatography o f OVA on a Cibacron Blue F3GA-agarose column. 1. Low 
molecular weight standard; 2. Starting material (OVA); 3. Fraction A; 9. Fraction B; 
10. Starting material. 7. An irrelevant experimental result.
3.3.3 Preparation of 125I-BSA and 125I-OVA
BSA and OVA were chosen for more detailed protein binding/elution studies 
using the PPy/dye system. Iodination of both proteins with 125I was carried out as 
described in Section 2.11.
Before iodination of OVA, several clean-up runs were carried out using the 
Cibacron Blue F3GA column and the same procedure as presented in Figure 3.4 (b). 
Fraction A and Fraction B were collected in each run, respectively. Collected Fractions 
A and Fractions B were dialysed against H20  overnight to remove low molecular 
weight material. After this step, the dialysed fractions were freeze dried. Fraction A 
yielded 2.4 mg OVA while nothing was recovered from Fractions B. This result was 
further evidence to prove that OVA didn’t bind to Cibacron Blue as expected from
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other studies [45], Fraction A (OVA) was thus radiolabelled for binding experiments. 
From its behaviour on the Cibacron Blue affinity column, it would not be expected to 
bind to either PPy/BD or PPy/CB membranes.
After labelling, chromatography of 125I-BSA and 125I-OVA on either the 
Cibacron Blue 3GA column or a Sepharose 4B column was carried out. 
Chromatography of proteins on the Sepharose 4B column served as control to show 
that the proteins did not bind non-specifically to the matrix. The results for both 
columns are shown in Figure 3.6. Neither BSA nor OVA bound to Sepharose 4B while 
only BSA bound to the Cibacron Blue F3GA-sepharose.
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Figure 3.6. a The elution profile for chromatography o f 125I-BSA on a Cibacron Blue 
3GA- agarose column (1 ml). The chromatographic procedure was as follows: a 1 ml 
CB column was equilibrated with 0.05 M  phosphate buffer pH 7.5, 450 pi 125I-BSA 
(1.3xl07 counts per minute (CPM), 25 pg) in H20  was loaded onto the column. 
Following this, the column was washed with 3.6 ml 0.05 Mphosphate buffer pH 7.5, 
400 pi fractions were collected. The arrow indicates the column was then eluted with 
7.2 ml 1M  NaCl in the same buffer. Each fraction was subjected to gamma counting.
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Figure 3.6.b The elution profile for chromatography o f 125I-BSA on a Sepharose-4B 
column (1 ml). In this chromatography, 50 p i125IBSA (1.4 x 106 CPM, 2.8 pg) in H2O 
was loaded. The column was then washed with 0.05 M  phosphate buffer pH 7.5. The 
arrow indicated the start o f elution with 1.0 MNaCl in the same buffer. Each fraction 
(200 pi) was subjected to gamma counting.
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Figure 3.6.c The elution profiles for chromatography o f125I-OVA on a Cihacron Blue 
column (1 ml) and a Sepharose-4B column (1 ml). For each experiment, 50 pi I- 
OVA (1.9x106 CPM, 2.8 pg) in H20  was loaded on the column which was eluted with 
0.05Mphosphate buffer pH 7.5 at 0.5 ml/minute. At arrow (i), the elution buffer was 
changed to 1 M  NaCl in the same buffer. Fractions of 200 pi were collected and 
subjected to gamma counting.
Figure 3.6.a shows that most of the 125I-BSA binds to the Cibacron Blue-agarose 
column with only a few counts not being retained. Several runs were carried out to 
obtain the bound portion of the labelled BSA. The combined Fractions B were dialysed 
against 0.05 M phosphate buffer, pH 7.5 for 4 hrs and concentrated in a Centricon 10 
ultra filter. This gave the labelled BSA that was used in experiments to determine 
binding to PPy/BD and PPy/CB membranes.
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125I-BSA and 125I-OVA was analysed by SDS-PAGE using a 10% 
polyacrylamide gel; the radioiodinated proteins were detected by autoradiography. 
From the result shown in Figure 3.7, the labelled proteins had the same mobility as the 
corresponding unlabelled proteins. These labelled proteins were therefore used in 
studies of binding and release from PPy/dye membranes.
1 2 3 4 5 6 7 8 9  10 1 2 3 4 5 6 7 8 9  10
(a) 10% SDS-PAGE (b) 10% SDS-PAGE
Coomassie Blue stained Autoradiography
Figure 3.7 SDS-PAGE of radiolabelled BSA and OVA using a 10% polyacrylamide 
gel The samples loaded in each slot are as follows: 1. Low molecular weight standard 
(Pharmacia); 2. 125l-OVA (Fraction A); 3. 125I-BSA (Fraction B); 4. 125I-BSA; 5. 
Unlabelled OVA; 6. Unlabelled BSA; 7. 125I-OVA; 8. 125l-OVA; 9. 125I-BSA (Fraction 
A); 10. 1251-BSA (Fraction B).
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3.3.4 125I-BSA and 125I-OVA Binding and Release Studies with PPy/dye 
Membranes
BSA and OVA binding to PPy/BD deposited on the platinised PVDF substrate 
was investigated. A PPy/pTS membrane served as the control membrane in this study. 
This was prepared by replacing the dye in the PPy membrane preparation with sodium 
p-toluene sulphonate (pTSNa). The binding studies using 125I labelled BSA and OVA 
with PPy/membranes were carried out in 1.5 ml Eppendorf tubes, in which the 0.5 cm x 
0.5 cm square of the PPy/membrane was incubated. The weight of each membrane was 
about 2.7 mg. Protein solution was made up with 50 pi 125I-BSA (2.1 x 105 CPM, 0.5 
pg) or 125I-OVA (2.0 x 106 CPM, 2.8 pg) in 300 pi 0.05 M phosphate buffer (pH 7.5). 
Each binding experiment was carried out by gently shaking the tube for about 90 
minutes. Then the supernatant and each PPy/membrane were taken off individually for 
gamma counting. The results are shown in Table 3.3. It was noted that the sum of the 
protein on the membrane and that remaining in the supernatant was less than the total 
amount of protein added into the binding solution for every experiment. The 
explanation for the lost protein could be:
(1) PPy membrane was rinsed in phosphate buffer before counting, and some of loosely 
bound protein could have been washed off. The washings were not added into the 
supernatant so that any protein in there was not counted. 2
(2) Non-specific binding on the wall of the Eppendorf tube may have led to some loss
of protein.
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In this work, the gamma counting on the PPy membrane after binding was used 
as the protein binding result, while gamma counting on the whole supernatant served as 
the non-binding result. The binding ratio of protein (Figure 3.8) was calculated by 
dividing the counts on the membrane by the sum of counts on the membrane and in the 
supernatant.













2.1xl05 CPM , 
500 ng
2.0 x 106 CPM , 
2800 ng
2.0 x 106 CPM, 
2800 ng





























7 2 6  ng
593037 CPM 
872 ng
Notes. PPy/pTS membrane was synthesised from a solution containing 0.2 M  pyrrole
and 0.05 M  pTSNa, with a constant current density o f 0.5 mA cm2 appliedfor 1 minute.
PPy/BD membrane was formed from an aqueous solution containing 5000 ppm Blue
Dextrcm with 0.5 M  pyrrole monomer, with a constant current density o f 0.5 mA cm 
supplied for 4 minutes.
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Figure 3.8 125I-BSA and 125I-OVA binding to PPy/pTS and PPy/BD membranes.
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As shown by Figure 3.8, BSA did not bind well to the membrane while OVA 
showed strong binding. In particular the binding of BSA to the PPy membrane with 
Blue Dextran was less than that to the control membrane with pTS. This difference 
was not seen with OVA which bound strongly to both membranes. The binding of 
OVA to these membranes is unexpected and is interpreted as being due to non-specific 
binding. Similarly the greater level of binding of BSA to the PPy/pTS membrane over 
the PPy/BD membrane probably also reflects a large non-specific component to the 
binding.
3.3.4.1 OVA binding experiments with membranes in different conditions
The binding of 125I-OVA to different membranes under various conditions was 
studied (Figure 3.9). In each 1.5 ml Eppendorf tube, 0.5 cm x 0.5 cm of membrane was 
incubated in 300 pi 0.05 M phosphate buffer (pH 7.5) containing 9.3 x 10'3 mg/ml 125I- 
OVA (2.0 x 106 CPM). Each binding experiment was carried out by gently shaking the 
tube for 90 minutes, and then the supernatant and PPy/membrane were taken off 
individually for gamma counting. The results (Figure 3.9) show that 125I-OVA was not 
strongly bound by the PVDF membrane alone (Group 1), but was bound by all other 
membranes. This suggests that perhaps the platinised surface is responsible for non­
specific binding in this case. Various effects were found from the use of different 
detergents. Thus the non-ionic detergent Triton X-100 (Group 4) had little effect on 
binding while the zwitterionic detergent Zwittergent 3-16 (Group 5) significantly 
reduced binding. The metal chelator EDTA had no effect on the non-specific binding
of OVA.
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Figure 3.9 OVA binding to different membranes under various binding conditions. 
PPy/BD membrane was formed in the solution o f 5000 ppm Blue Dextran with 0.5 M  
pyrrole, with a constant current density o f 0.5 mA cm 2 appliedfor 4 minutes. Group 1, 
OVA binding with plain PVDF. Group 2, OVA binding on Pt/PVDF/Pt membrane. 
Group 3, OVA binding on PPy/BD membrane. Group 4, OVA binding on PPy/BD with 
0.1% Triton X-100. Group 5, OVA binding on PPy/BD with 1% ZWITTERGENT 3-16 
detergent (Calbiochem). Group 6, OVA binding on Pt/PVDF/Pt with 0.01 M  EDTA
added.
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3.3.4.2 Other factors influencing BSA and OVA binding
As ethanol in aqueous solution could make the contacting surface wet more 
evenly, the binding experiment was carried out with either pre-wetted or un-wetted 
PPy/membranes. The size of each test membrane was 0.5 cm x 0.5cm. The pre-wetted 
PPy membranes were prepared by incubating the membranes in 50% ethanol for 15 
minutes, and then rinsing them thoroughly with distilled water, without allowing the 
membrane to dry. The binding test was carried out in 300 pi 0.05 M phosphate buffer 
(pH 7.5) containing 0.7 x 10-3 mg/ml (9.8 x 104 CPM) or 1.7 x 103 mg/ml (2.4 x 105 
CPM) 125I-BSA overnight. As shown in Figure 3.10, BSA binding increased 
significantly when the PPy/membranes were pre-wetted. Similarly the binding of OVA 
was also increased by a preliminary wetting with 50% ethanol (data not shown). Other 
influences on the binding of BSA to PPy/BD membranes are the binding time, 
concentration of protein and pH of the binding solution. These are illustrated in Figure
3.11.
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Figure 3.10 BSA binding to pre-wetted and un-wetted PPy/BD membrane. The 
PPy/BD membrane used in this experiment was synthesised in 1000 ppm Blue Dextran 
with 0.5 M  pyrrole, with a constant current density o f 0.5 mA cm applied for 4
minutes.

















Figure 3.11. a The effect of binding time on amount of BSA bound to PPy/BD 
membranes. The experiment was carried out by incubating 0.5 cm x 0.5 cm PPy/BD 
membranes in 300 pi phosphate buffer pH 7.5 with either 10 pi (4.9 x 104 CPM, 0.1 pg) 
or 20 pi (9.8 x 104 CPM, 0.2 pg) 125I-BSA for 90 minutes or 15 hrs. The membrane 
was then washed and counted. The PPy/BD membrane was formed as in Figure 3.10.
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Figure 3.11.b The effect of protein concentration on the amount of BSA bound to the 
PPy/BD membrane. The experiment was carried out by incubating 0.5 cm x 0.5cm 
PPy/BD membranes in 300 pi phosphate buffer pH 7.5 with 10 pi (4.9 x 104 CPM, 0.1 
jig), 20 ¡A (9.8 x 104 CPM, 0.2 ¡ug) or 50 ¡A (2.4 x 10s CPM, 0.5 jug) 12SI-BSA 
overnight. The membrane was then washed and counted. The PPy/BD membrane was 
formed as in Figure 3.10.
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Figure 3.11.C The effect of pH of binding solution on the amount of BSA or OVA 
bound to the PPyfBD membrane. Squares of PPy/BD membrane (0.5 cm x 0.5 cm) 
were incubated in 350 pi 0.05 M phosphate buffer (pH 4.6 or pH 7.5) containing either 
50 ¡A I25I-BSA (2.4 x 1(?CPM) or 50 fd I2SI-OVA (1.9 x l ( f  CPM) for 90 minutes. The 
membrane squares were then washed and counted. PPy/BD membrane for BSA 
binding was prepared as described in caption to Figure 3.10. PPy/BD membrane for 
OVA binding was formed as described in caption to Table 3.3.
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3.3.4.3 The effect of casein pre-treatment on BSA and OVA binding
In an attempt to reduce non-specific binding the membrane was subjected to a 
pre-treatment with casein, a major phosphoprotein found in milk. The binding 
experiment was carried out with 0.5 cm x 0.5 cm squares of PPy/BD, Pt/PVDF/Pt and 
PPy/pTS membranes. Each membrane was pre-wetted with 50% EtOH for 15 minutes, 
and then thoroughly rinsed with distilled water. The squares were then incubated in a 
protein solution made by adding 20 pi 125I-BSA (9.4 x 105 CPM) or 20 pi 125I-OVA 
(8.2 x 105 CPM) to 300 pi 0.05 M phosphate buffer (pH 7.5) either with or without 
added casein (1%). Protein binding was carried out by gently shaking, for 90 minutes. 
The results (Figure 3.12) show that 1% casein added into the binding solution almost 
eliminated BSA binding but only slightly reduced the binding of OVA.







I  2000 
3  1000 
0
PPy/BD Pt/PVDF/Pt PPy/pTS













üW ith casein 
® Without casein
Figure 3.12 The effect of 1% casein on BSA and OVA binding. The binding was 
carried out in 0.05 M  phosphate buffer with or without 1% casein. PPy/BD was 
formed as described in Figure 3.10. PPy/pTS was polymerised as described in caption 
to Table 3.3. After 90 minutes the membrane squares were washed and counted.
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3.3.4.4 Release of bound 125I-BSA and 125I-OVA from PPy/dye/Pt/PVDF/Pt 
membranes
The BSA and OVA release experiments were carried out, by incubating BSA and 
OVA bound PPy membranes in various elution buffers by gently shaking for various 
periods of time. The membrane and the supernatant were then counted. The difference 
in the gamma count obtained for the PPy membrane before and after washing gave the 
level of BSA and OVA released.
BSA and OVA release using high ionic strength media was studied. Membrane 
squares (0.5 cm x 0.5 cm) loaded with either OVA or BSA were incubated in 350 pi 1 
M NaCl, 0.05 M phosphate buffer, pH 7.5. At various times the supernatant was 
removed and replaced with fresh buffer. Finally, the protein remaining bound was 
determined by counting the membrane. Though, as mentioned above, OVA bound in 
large quantities to the membrane only small quantities (2.7 ~ 3.7% of total bound) could 
be released by overnight elution (Table 3.4). In other elution experiments, it was found 
that OVA release was not improved by extending the elution time. When it was eluted 
for as long as 41 hours, the result showed the elution ratio was less than 1% (result not 
shown). BSA could not be eluted from PPy membranes, even after 48 hours in 1 M 
NaCl (result not shown).
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Table 3.4 Release o f OVA from PPy/pTS and PPy/BD membranes, by elution with 1M 
NaCl.
PPy/pTS membrane Starting 10 min 20 min 40 min overnight
M em brane su pern atan t su pern atan t supern atan t su pernatan t m em brane
Gamma count, C P M 462825 6593 1809 1173 1711 445558
Amount of OVA, ng 680 10 3 2 3.5 655
(a) 3.7% OVA was eluted.
P P y /B D  membrane Starting 10 min 20 min 40 min overnight
M em brane supern atan t supern atan t su pernatan t supernatan t m em brane
Gamma count, C P M 485841 3804 1029 666 1407 472711
Amount of OVA, ng 714 5.6 1.5 1 2 695
(b) 2.7% OVA was eluted.
3.3.5 Further study of BSA and OVA binding and release
The preliminary experiments with BSA and OVA discussed above showed that 
binding was non-specific and release not efficient. Besides non-specific binding sites 
on PPy/dye membranes, the question of whether there are specific binding sites 
resulting from the incorporation of dye molecules into the membrane still needs to be 
settled. This was tested by a series of experiments in which an attempt was made to 
block all non-specific binding sites by pre-incubation with first casein, then OVA. The 
possibility of further uptake of OVA was then measured using labelled OVA and then 
uptake of labelled BSA was studied. The effect of time on binding of 125I-OVA was
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determined by removal and counting of the membrane; which gave a measure of the 
binding or exchange of OVA on the PPy/BD membrane.
The results (Figure 3.13) show that even after pre-incubation with casein and 
unlabelled OVA, there was still a rapid uptake of labeled OVA. This leveled off after
4.5 hrs with about 45% of the labelled OVA bound to the membrane; after this, there 
was a slow release of counts from the membrane. The release of labelled OVA is better 
seen in Figure 3.14 where only the latter part of the binding vs time profile is shown for 
a repeat experiment.













Figure 3.13 OVA binding as a function of time. Squares 0.5 cm x 0.5 cm of PPy/BD 
membrane, synthesised as described in caption to Figure 3.10, was incubated in 300 pi 
of 0.05 M  phosphate buffer containing 1% casein, pH 7.5, for 2 hrs. Then 20 pi o f 1 
mg/ml unlabelled OVA was added, and the incubation continued by gentle shaking 
overnight. Following this, an additional 20 pi of 1-OVA (8.2 x 10 CPM) was added. 
After the time indicated, the membrane squares were washed and subjected to gamma
counting.
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Figure 3.14 OVA binding as a function of time. PPy/BD membrane was formed as 
described in caption to Figure 3.10, and cut into squares (0.5 cm x 0.5 cm). A 
membrane square was incubated in 300pi 0.05 M  phosphate buffer containing 1% 
casein for 2 hrs and then in 20 pi unlabelled lmg/ml OVA for 180 minutes. After this, 
the membrane was transferred to the protein solution with 20 pi 125I-OVA (8.2 x 105 
CPM) for further binding.
The PPy/BD membrane used for the experiment shown in Figure 3.13 was shown 
to be fully saturated with OVA. In order to test whether this membrane would still take 
up BSA, it was incubated in 350 |il of 0.06 mg/ml 125I-BSA (8.6 x 104 CPM) in 0.05 M 
phosphate buffer (pH 7.5) for 2 hrs. After this time the membrane was then washed and 
counted. The results (Table 3.5) show that little, if any, of the labelled BSA had bound 
to this membrane; in that the total counts went down. Perhaps this suggests that some
125I-OVA was released.
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Table 3.5 ]25I-BSA binding result o n 125 1-OVA treated (48.5 hrs) PPy/BD membrane.
Content in solution












A series of experiments was carried out to study the effect of pre-incubation of 
various membranes with unlabelled BSA on subsequent binding o f 1 I- labelled BSA. 
Figure 3.15 shows the results of an experiment to study BSA binding to PPy 
membranes as a function of time. PPy membranes, PPy/pTS, PPy/BD and PPy/CB, 
were cut into squares, 0.6 cm x 0.6 cm. Duplicates of each of them was pre-wetted in 
50% ethanol for 15 minutes, and rinsed thoroughly with distilled water, and then 
incubated in 1 ml of 1 mg/'ml unlabelled BSA solution in 0.05 M phosphate buffer (pH 
7.5) for various times. One group of PPy membranes was then incubated in 1 ml 0.05 
M phosphate buffer, pH 7.5, overnight, while the other group was incubated in 1 ml 
0.05 M phosphate buffer with 1 M NaCl, pH 7.5, overnight. Following this, each group 
of PPy membranes was incubated in 1 mi of 0.05 M phosphate buffer (pH 7.5) 
containing 5 x 10'5 mg/ml 125I-BSA (9.4 x 105 CPM) for 2 hrs, then was detected by 
gamma counting to measure further binding of BSA. Given the results shown in Figure 
3.15 several points can be made:
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1) None of the membranes (PPy/pTS, PPy/BD, PPy/CB) were saturated with BSA even 
after incubation in lmg/ml BSA for 5 days. Even after this time further I BSA was 
rapidly taken up or exchanged for unlabelled BSA on the membrane.
2) Washing overnight with 1M NaCl releases some of the bound BSA, so that more 
labelled BSA was subsequently bound.
3) There is no obvious explanation in terms of a specific interaction between BSA and 
Cibacron Blue to explain the different binding patterns for the three membranes, though 
BSA is known to bind, non-specifically, to hydrophobic molecules such as fatty acids.
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Figure 3.15 BSA binding to PPy membranes as a function o f time. Membranes in 
squares were incubated with unlabelled BSA for the stated times. One o f each pair was 
then washed overnight with or without 1 M  NaCl. Both were then tested for further 
BSA binding with 1 ml o f 0.05 M  phosphate buffer (pH 7.5) containing 5 x 10'5 mg/ml 
125I-BSA (9.4 x 105 CPM) for 2 hrs. PPy/pTS membrane was formed in 0.05 MpTSNa 
and 0.2 M  pyrrole with constant current density o f 0.5 mA cm 2 applied for 4 minutes. 
PPy/CB membrane was grown in 100 ppm Cibacron Blue and 0.5 M  pyrrole with 
constant current density o f 0.5 mA cm 2 appliedfor 4 minutes. PPy/BD membrane was 
synthesized in 2000 ppm Blue Dextran and 0.5 Mpyrrole with constant current density 
o f 0.5 mA cm 2 appliedfor 4 minutes.
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To further study BSA binding, 0.6 cm x 0.6 cm squares of PPy/pTS, PPy/BD and 
PPy/CB membranes were pre-wetted with ethanol. Then each of them was incubated in 
1 ml of 1 mg/ml unlabelled BSA in 0.05 M phosphate buffer (pH 7.5) for a period 
ranging from 0 hr to 72 hrs. After that, each membrane was incubated in 1 ml 0.05 M 
phosphate buffer (pH 7.5) overnight. Following this, each membrane was incubated in 
1 ml 1 mg/ml unlabelled BSA in 0.05 M phosphate buffer (pH 7.5) containing 5 x 10'5 
mg/ml 125I-BSA (9.4 x 105 CPM) for 2 hrs. Finally, gamma counting of each membrane 
was carried out. The results in Figure 3.16 show that the binding of radiolabelled BSA 
is reduced by pre-incubation with BSA itself. Increasing the time of the pre-incubation 
lead to further reduction in the binding of labelled BSA. This effect presumably results 
from binding of unlabelled BSA to the membranes; most of this binding seems to take 
place within the first two hours of pre-incubation.
The results shown in Figure 3.16 seem to be at variance with the results of the 
previous experiment (Figure 3.15) which suggested that even after pre-incubation with 
unlabelled BSA for several days there was still further uptake of labelled BSA. The 
crucial difference between these two experiments is that the 125I-BSA in the earlier 
experiment was not diluted with unlabeiled BSA while the later experiment was diluted 
with 1 mg/ml unlabeiled BSA. So there was more BSA bound in the experiment 
(Figure 3.16).
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(a)
Figure 3.16. BSA binding as a function of time (a), and from 2hrs to 72hrs (b). The 
pre-wetting time ”Ohr to 72hrs ” refers to the time that PPy membranes were incubated 
in unlabelled BSA in phosphate buffer before they were incubated in the labeled BSA 
for 2 hrs. All the membranes used were prepared as described in Figure 3.15. Binding 
o f BSA was determined by gamma counting on the membrane.
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In order to assess the rate of exchange of BSA on the different PPy membranes, 
two groups of membranes were prepared as described in caption to Figure 3.15. After 
incubation with BSA solution as described earlier for 48 hrs one group was washed 
overnight with 0.05 M phosphate buffer, pH 7.5, while the other was washed with the 
same buffer containing 1.0 M NaCl. Each was then loaded with 125I-BSA by incubation 
in 1 ml phosphate buffer containing 50 ng BSA (9.4 x 105 CPM) for 2 hrs.
To measure the rate of exchange of BSA on the membrane, these membranes 
were then incubated again with unlabelled BSA in phosphate buffer. Thus each PPy 
membrane square was soaked in 1 ml 5 mg/ml BSA in 0.05 M phosphate buffer, pH 
7.5, for 24 hrs. Finally, a gamma count on each membrane and 200 pi of each 
supernatant was carried out. Table 3.6 shows that few counts were found in the 
supernatant after the final treatment suggesting that no significant exchange takes place. 
There is a slight reduction in the membrane count after BSA exchange, and so the 
overall conclusion for this experiment is that there is little exchange of BSA under the 
conditions of the experiment.
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(counton (count on 200 
membrane) pi supernatant)
PPy/pTS, without soaking in salt 5073 4945 115
PPy/pTS, with soaking in salt 4926 4710 119
PPy/BD, without soaking in salt 1479 1023 66
PPy/BD, with soaking in salt 1921 1870 91
PPy/CB, without soaking in salt 4073 3726 103
PPy/CB, with soaking in salt 6465 5639 142
3.3.S.2 BSA release
In the previous Figure 3.15, 125I-BSA binding on PPy membranes, which had 
been incubated in 1 M NaCl after pre-incubation with unlabelled BSA, was 
significantly greater than on the PPy membrane incubated without salt. The reason for 
this was presumably that 1 M salt removed some unlabelled BSA from the PPy 
membrane, indicating that the “non-specific” binding of BSA to these membranes had 
some ionic character. Using the membranes from the experiment reported in Figure 
3.16, the release of BSA was studied. These membranes were incubated overnight in 1 
M NaCl in 0.05 M phosphate buffer and counted to determine the BSA that was still
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bound. The results are shown in Figure 3.17, which shows the percentage of BSA 
released from each membrane. Though there is some scatter within these sets of data, 
the release of BSA from the two sets of membranes with dye incorporated (PPy/BD and 
PPy/CB) is consistently higher than those from the control membranes, PPy/pTS. 
These results are comparable to those obtained previously (see page 73). Membranes 
that had not been pre-treated with BSA released very little labelled BSA during the 
high-salt wash (data not shown).
PPy/pTS
^  10000 
c
2 hr 6 hr 24 hr 48 hr 72 hr 
Different group of PPy/pTS
^Before release ® After release
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Figure 3.17 BSA release from PPy/pTS, PPy/CB and PPy/BD membranes. The release 
ratio is shown as the percentage of counts released over total counts; counts released 
are calculated as the difference in counts of each membrane before and after treatment 
with 1 M  NaCl. ”0 hr ” to “72 hrs” in different groups refers to the duration that PPy 
membranes had been pre-incubated in the unlabelled BSA before they were incubated 
in the labeled BSA. The PPy membranes used in these experiments were the same as 
those membranes usedfor the binding results shown in Figure 3.16.
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After completion of the previous experiment, the final membranes were washed 
with 8 M Urea solution, but there was still no further release of labelled BSA (result not 
shown).
3.3.6 125I-BSA and 125I-OVA Binding and Release on/from PPy membrane 
without Platinum
As a platinum surface results in a large amount of non-specific binding when not 
coated with polymer as described in Section 3.3.4.1, a series of binding and release 
experiments with PPy membranes on stainless steel, free standing PPy/membranes and 
on RVC were carried out.
3.3.6.1125I-BSA and 125I-OVA binding and release on/from PPy membranes on 
stainless steel (SS)
The results in Table 3.7 show that very little BSA or OVA bound to the stainless
steel wires.
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SS, 1.5cm 0.8 x 10'J mg/ml 12:>I- 
OVA (2.1 x 106CPM) in 
0.05 M phosphate buffer 
pH7.5





SS,1.5cm 1.1 x 10'3 mg/ml 125I- 
BSA (2.1 x 105CPM) in 
0.05 M phosphate buffer 
pH7.5





Note. The binding ratio  o f  protein  was calculated by dividing the counts on the 
membrane by the sum o f  counts on the membrane and in the supernatant (see page61- 
62).
For BSA and OVA binding experiments with PPy/BD/SS, the polymer-coated 
substrate was also cut into 1.5 cm lengths. PPy/pTS/SS was made and served as 
control. The preparation details are described in Section 3.2. The binding experiment 
was carried out using the same procedures as described in Table 3.7. As the PPy/BD 
membrane covered the stainless steel, there was almost no stainless steel directly in 
contact with the solution, except for a very small circle at the end where the wire had 
been cut. The result presented in Figure 3.18 showed that by removing the interference 
from platinum, BSA and OVA binding decreased significantly, which could be 
compared with the data in Section 3.3.3.1. For both PPy/pTS and PPy/BD membranes 
the binding of OVA was greater than that of BSA. However for BSA there was greater 
binding to the PPy/BD membrane than to the PPy/pTS membrane while for OVA the 
reverse was true. This suggests that the Blue Dextran was influencing binding of BSA, 
possibly against a background of non-specific binding.
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Figure 3.18 BSA and OVA binding with PPy/BD and with PPy/pTS deposited on 
stainless steel wire. The binding ratio of protein was calculated as described in Table
3.7.
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BSA and OVA bound on PPy membranes were difficult to elute using 1 M salt. 
Elution could be achieved through the use of buffer of pH 11.9 (results not shown), but 
this led to a breakdown of the membrane binding to the steel surface and the experiment 
was discontinued.
3.3.6.2125I-BSA and 125I-OVA binding and release on/from free standing PPy 
membranes
A further series of experiments was carried out using free standing membranes 
prepared by published methods [112]. Free standing membranes PPy/pTS/BD and 
PPy/CKVCB were prepared on stainless steel plate or stainless steel wire using 
polymerization in propylene carbonate-containing solution. These could be readily 
peeled from the metal electrode unlike membranes prepared in 100% water that could 
not be removed from the electrode. Membranes prepared with BD or CB alone as 
counterion were also difficult to peel from the electrode. The polymerization conditions 
of these membranes are shown in Table 3.8.
Table 3.8 Polymerization conditions used to make free standing PPy membranes.
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PPy membranes Polymerisation conditions
PPy/pTS 0.03 M pTSNa + 0.6 M pyrrole + 66% propylene carbonate, with 
applied constant current density of 0.5 mA cm"2 for 5 minutes
PPy/C104 0.02 M NaC104 + 0.6 M pyrrole + 72% propylene carbonate, with 
applied constant current density of 0.5 mA cm'2 for 4 minutes
PPy/pTS/BD 0.05 M pTSNa + 5000 ppm BD + 2.5 M pyrrole + 50% propylene 
carbonate, with applied constant current of 0.5 mA cm'2 for 4 
minutes
PPy/CKVCB 0.01 M NaC104 + 500 ppm CB + 1.35 M pyrrole + 77% 
propylene carbonate, with constant current of 0.5 mA cm'2 
applied for 4 minutes
Notes. The electrochemical polymerization was carried out in the cell shown in Section
2.1
Each PPy membrane was peeled off after growth on the stainless steel substrate. 
It was soaked in propylene carbonate for 1 hour, then soaked in absolute ethanol to 
remove loosely deposited polymer; following this it was vacuum dried at 50 °C
overnight. After free-standing PPy membranes had been synthesized, they were 
cleaned for XPS analysis. To clean these PPy membranes, they were washed in 
absolute ethanol for 2 hrs, and then soaked in acetonitrile with continuous stirring for 1
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hr. After this, they were washed with propylene carbonate followed by distilled water. 
Finally, they were vacuum dried at room temperature overnight.
The XPS results (presented in Table 3.9) showed that the sulphur content (a 
measure of dye incorporation) was much higher than for membranes polymerized from 
aqueous solution (compare with Table 3.2).
Table 3.9 XPS results. 
a) PPy/pTS
pTsNa P y Current Time N% C% 0 % S%
0.03 M 0.6 M 8 mA 5 minutes 2.58 76.95 18.4 2.07
b) PPy/pTS/BD
pTsN a BD P y Current Time N% C% 0 % S%
0.05 M 5000 ppm 2.5 M 8 mA 4 minutes 2.54 70.3 23.49 3.67
c) PPy/C104
NaCIO t Py Current Time N% C% 0 % S% Cl%
0.02 M 0.6 M 8 mA 5 minutes 3.98 72.34 20.3 0.11 3.26
d) PPy/ C1047CB
N a C I0 4 CB Py Current Time N% C% O % S%
0.01 M 500 ppm 1.35 M 8 mA 4 minutes 1.43 68.14 26.21 4.23
Notes. Membranes prepared as described in Table 3.8.
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BSA and OVA binding studies were carried out using these free standing PPy 
membranes. Squares, 0.5 cm x 0.5 cm, of PPy/pTS/BD, PPy/C1 0 4  and PPy/C1 0 4 /CB 
membranes were incubated in 350 pi of 1.3 x 10'3 mg/ml 125I-BSA (2.1 x 105 CPM) or
1.1 x 10'3 mg/ml 125I-OVA (3.4 x 106 CPM) with 0.05 M phosphate buffer (pH 7.5) for 
160 minutes. After this time, the protein bound was determined by counting the 
membrane and supernatant. The results presented in Figure 3.19 show that the PPy 
membranes, without support, bound much less protein. The two dye containing 
membranes bound less BSA than the control membrane (CIO4 containing) suggesting 
that the binding mechanism is not based on a specific interaction of BSA with the dye.
BSA binding 
on PPy m em branes
□  Nonbinding s  Binding
Figure 3.19 BSA and OVA binding results on PPy membrane. The binding ratio of 
protein was calculated as described in Table 3.7.
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BSA and OVA release experiments using these membranes were also carried out 
using the elution buffers as follows: (a) 0.05 M phosphate buffer (pH 7.5), (b) 1 M 
NaCl in 0.05 M phosphate buffer (pH 7.5), (c) 0.05 M phosphate buffers (pH 10-13.5). 
BSA release was minimal, even when buffers of pH 10-13.5 were used (result not 
shown). However, OVA release was easily achieved (Figure 3.20). OVA could be 
eluted from the PPy membranes even when using 0.05 M phosphate buffer (pH 7.5), 
without salt. Elution was improved when 1 M salt was included. 94% of the OVA 
could be removed from PPy/pTS/BD membrane, 86% from PPy/C1 0 4  membrane and 
87% from PPy/ClOVCB membrane after the series of washing steps shown (Figure
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Figure 3.20 OVA release from PPy/pTS/BD membrane, PPy/Cl04 membrane, and 
PPy/ClOpCB membrane. Elution steps were: (1) Starting PPy membranes with OVA 
bound (see Figure 3.19 for details of the binding); (2) OVA was eluted in 350 pi of 
0.05 Mphosphate buffer, pH 7.5, for 2 hrs; (3) OVA was eluted in 350 pi o f 1 M  NaCl 
in 0.05 Mphosphate buffer, pH 7.5, for 2 hrs; (4) OVA was eluted in 350 pi o f 1 M  
NaCl in 0.05 Mphosphate buffer, pH 7.5, for 18 hrs; (5) OVA was eluted in 350 pi of 
0.05 Mphosphate buffer, pH 7.5, for 2 hrs; (6) OVA was eluted in 350 pi o f 0.05 M  
phosphate buffer, pH 7.5, for 2 hrs; (7) OVA was eluted in 350 pi of 0.05 Mphosphate 
buffer, pH  7.5, for 2 hrs; (8) OVA was eluted in 350 pi of 0.05 Mphosphate buffer, pH  
7.5, for 18 hrs. After each step the membrane was counted to assess protein still bound.
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3.3.6.3125I-BSA and 125I-OVA binding and release from PPy deposited on RVC
PPy/CB and PPy/pTS were deposited on RVC, and this was then cut into cubes of 
5 mm x 5 mm x 3 mm along with RVC itself. Cubes of each of the three RVC samples 
were incubated in phosphate buffer, 1 mg/ml OVA or 1 mg/ml BSA in phosphate buffer 
for 48 hrs. Each sample was then washed with phosphate buffer and incubated in 1 ml 
0.1 mg/ml unlabelled BSA, with 5.5 x 10’5 mg/ml 125I-BSA added for 2 hrs. The release 
experiment was then carried out by incubation in 1 ml phosphate buffer with 1 M NaCl 
for 24 hrs.
Binding results are shown in Figure 3.21. These show: (1) Labelled BSA is taken 
up by all samples when the pre-incubating buffer does not contain protein. (2) Pre­
incubating with buffer containing either BSA or OVA significantly reduced the binding 
of labelled BSA to all samples. The small amount of additional binding of labelled 
BSA to the PPy/CB membrane may be an indication of specificity.
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Figure 3.21 BSA binding on PPy membranes deposited on RVC. The binding was 
carried out after pre-incubation in phosphate buffer without or with either 1 mg/ml 
OVA or 1 mg/ml BSA for 48 hrs. Each sample was then washed with phosphate buffer 
and incubated in 1 ml 0.1 mg/ml BSA, with 9.4 x 105CPM o f125I-BSA (1 pg BSA-9.4 x 
103 CPM) added for 2 hrs. PPy/CB/RVC was formed in 100 ppm Cibacron Blue with 
0.5 M  pyrrole, under constant 1 mA (2 cm lengths o f RVC was immersed in the 
polymerization solution) applied for 30 minutes. PPy/pTS/RVC was synthesized in a 
solution o f 0.05 M  pTSNa and 0.2 M  pyrrole with constant 1.5 mA (2 cm lengths of 
RVC) suppliedfor 20 minutes.
More than half of the BSA could be eluted by phosphate buffer containing 1 M 
NaCl in 24 hrs (Figure 3.22). This result showed that significantly more protein was 
released than with the release experiment on PPy/Pt/PVDF/Pt/membrane.
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Figure 3.22 BSA release from PPy/CB/RVC, PPy/pTS/RVC and RVC The elution was 
carried out for 24 hours in 1 ml phosphate buffer containing 1 M  NaCl. Protein 
released is shown as a percentage o f the amount bound, (a) ~ (c) show the different 
groups with different binding conditions ( refer to Figure 3.21):
(a) Pre-soaking in 1 ml 5 mg/ml OVA.
(b) Pre-soaking in 1 ml 5 mg/ml BSA.
(c) Pre-soaking in 1 ml 0.05 Mphosphate buffer.
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3.3.7 Transport of 125I-BSA and 125I-OVA with PPy membranes under 
Electrochemical Control
The transport cell (15 ml) shown in Section 2.3 was used. All PPy membranes 
used in these experiments were single-sided PPy membranes deposited on platinised 
PVDF. In protein transport studies, constant current and constant potential control were 
used.
3.3.7.1 Transport of 125I-BSA using constant current
To study BSA transport through PPy/BD membrane, an experiment was set up in 
which labelled BSA was placed in the feed solution of a transport cell as shown in 
Section 2.3. Initially the effect of simple diffusion under a concentration gradient was 
studied. Here, with no applied potential, samples were withdrawn from the feed 
solution at intervals for gamma counting. After allowing this to proceed overnight, a 
positive current of 0.64 mA cm'2 was applied. Samples were again withdrawn at 
intervals for 4 hrs. After this the current was reversed and samples were again 
withdrawn for gamma counting for a further 3 hrs.
Thus a PPy/BD membrane was prepared using 5000 ppm Blue Dextran with 0.5 
M pyrrole monomer, a current density of 0.5 mA cm'2 was applied for 4 minutes. Prior 
to placing in the cell the membrane was pre-wetted with 50% ethanol for 5 minutes, and 
then rinsed with distilled water. To each side of the cell, 15 ml of 0.05 M phosphate 
buffer (pH 7.5) was added; the feed solution was charged with BSA by addition of 20 pi 
125I-BSA (3.1 x 106CPM, 0.17 pg BSA). Aliquots of 100 pi were removed from both
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the feed and receiving solution for counting; after counting they were returned to the 
appropriate cell.
The results of this diffusion experiment are shown in Figure 3.23. These show 
that the BSA concentration in the feed solution decreased dramatically in the first 20 
minutes and after that remained almost constant. However, the counts in the receiving 
solution were not significant — 117 CPM (per 100 pi supernatant) after 90 minutes and 
87 CPM (per 100 pi supernatant) overnight. There was very little transport from the 
feed side to the receiving side, and the decrease in BSA concentration in the feed 
solution was caused by BSA binding to the membrane as discussed previously.
Figure 3.23 Gamma count for BSA in feed solution as a function of time. No 
electrochemical control was used. The gamma counting was carried out on aliquots of 
100 pi removedfrom the feed solution.
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The results of the experiments on transport under electrochemical control are 
shown in Figure 3.24 (+ 0.64 mA cm’2) and Figure 3.25 (- 0.64 mA cm’2). No counts 
were found in the receiving solution for either experiment so that the changes in the 
feed solution reflect transport to and from the membrane.
For both positive and negative current control, oscillations are seen in the 
apparent concentration of BSA in the feed solution. The reason for these oscillations is 
not obvious, and they may be due to a subtle experimental artifact or simply 
experimental error.
Figure 3.24 The amount of BSA in the feed solution with constant current density o f + 
0.64 mA cm 2 applied. Gamma counting was carried out on aliquots of 100 pi removed 
from the feed solution.
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Figure 3.25 The amount of B SA in the feed solution with a constant current density o f-  
0.64 mA cm . Gamma counting was carried out on aliquots of 100 pi removed from 
the feed solution.
3.3.7.2 125I-BSA and 125I-OVA transport studies using constant potential
BSA transport using constant potential (+/- 1.5 V) was investigated. PPy/pTS, 
PPy/BD and PPy/CB membranes deposited on platinised PVDF were used in this study. 
The electrochemical polymerisation conditions were: (1) For PPy/pTS (0.05 M pTSNa 
+ 0.2 M pyrrole, constant current density of 0.5 mA/cm2, 1 minute); (2) for PPy/BD 
(1000 ppm Blue Dextran + 0.5 M pyrrole, constant current density of 0.5 mA/cm2, 4 
minutes); (3) for PPy/CB (100 ppm Cibacron Blue + 0.5 M pyrrole, constant current 
density of 0.5 mA/cm2, 2 minutes). All the membranes were prewetted by soaking in 
50% EtOH for 15 minutes, then rinsing thoroughly with distilled water. Following this, 
membranes were equilibrated in 0.05 M phosphate buffer (pH 7.5) for 2 hrs, and then
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incubated in 1% casein with 0.05 M phosphate buffer (pH 7.5) overnight in an effort to 
reduce non-specific binding to the membranes as found in the experiments with 
constant current (Section 3.3.4.1).
3.3.7.2.1 BSA transport using constant potential control with the PPy/pTS 
membrane
The PPy/pTS membrane was placed in the transport cell as shown in Section 2.3. 
The composition of the feed solution was 15 ml of 2.9 x 10'5 mg/ml 125I-BSA (7.7 x 106 
CPM) in 0.05 M phosphate buffer at pH 7.5. The receiving solution consisted of 15 ml 
of 0.05 M phosphate buffer pH 7.5. Two hours after assembly of the experimental set 
up the potential (- 1.5 V) was applied. 100 pi of supernatant from each side was 
removed for gamma counting of the BSA. BSA binding to the PPy/pTS membrane was 
measured by counting the membrane at the conclusion of the experiment.
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(100 pi supernatant)




Notes. * without potential applied.
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Table 3.11 shows that in the 2 hrs before the application of potential to the cell 
there was a small amount of difiusion of BSA into the receiving solution — 364 
CPM/100pl. The applied potential seemed to make no difference to the rate of transport 
so that after a further 22 hrs only 2261 CPM/lOOpl were found in the receiving solution.
During the 24 hrs time span of this experiment, a small amount of labelled BSA 
bound to the membrane — 1.4 ng out of a total of 430 ng. In order to study the release 
of this protein, the membrane was place in a transport cell with 15 ml 0.05 M phosphate 
buffer (pH 7.5) added to each side. After 2 hrs a potential of + 1.5 V was applied. Very 
little BSA (0.1 ng) was released under these conditions as shown in Table 3.12, by the 
difference in counts before and after the release experiment. Though the counts 
measured for the two supernatants are only just above the background count (60 — 120 
CPM), most of the released BSA was found in the feed solution as expected from the 
polarity of the applied potential.












232 250 171 187
Receiving solution 
(100 pi supernatant)




Notes. * .without potential applied. Release o f BSA was followed by counting aliquot o f 
100 p i supernatant, after which the membrane itself was counted.
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3.3.7.2.2 BSA transport with constant potential control for the PPy/BD membrane
Both the receiving and feed solution consisted of 15 ml 0.05 M phosphate buffer 
(pH 7.5), but to the feed solution an additional 2.9 x 10'5 mg/ml 125I-BSA (7.7 x 106 
CPM) was added. After the first 2 hrs, a constant potential o f -  1.5 V was applied. 100 
pi of supernatant from each side were taken off for counting at various intervals (see 
Table 3.13). At the end of the experiment the membrane itself was counted.
Table 3,13 Gamma count during BSA transport experiments using a PPy/BD 
membrane.













Notes. A constant potential o f -  1.5 was applied after 2 hrs.
Again, with this membrane there is no evidence of transport under the influéhce 
of applied potential. Over 26 hrs some 3 % of the original BSA migrated to the 
receiving solution, but this can be accounted for totally by diffusion under the 
concentration gradient.
The possibility of inducing BSA release was investigated by an experiment 
similar to that carried out with the PPy/pTS membrane (see page 104). The results
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(Table 3.14) show the apparent release of 19 % of the bound BSA during the overnight 
experiment.
Table 3.14 Gamma count obtained during BSA removal from the PPy/BD membrane 
with a constant applied potential
Feed solution Receiving solution PPy/BD membrane
(100 (il supernatant) (100 (il supernatant)
153 140 20505
(11 ng)
3.3.7.2.3 BSA transport using constant potential control with the PPy/CB 
membrane
Transport of BSA through a PPy/CB membrane was studied using a set-up 
similar to that used for transport through the membranes PPy/pTS and PPy/BD. In the 
feed solution 2.9 x 10’5 mg/ml 125I-BSA (7.7 x 106CPM) in 15 ml 0.05 M phosphate 
buffer (pH 7.5) was added. Transport with a constant potential o f -  1.5 V was followed 
by counting aliquots of lOOjil from each of the feed and receiving solutions at various 
times. Results are shown in Table 3.15 and Figure 3.26.
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Table 3.15 Transport o f BSA as a function o f time with the PPy/CB membrane using a
constant potential -  1.5 V.
1 hr 2 hrs 3 hrs 4 hrs 16 hrs 21 hrs 23 hrs 25 hrs
Feed solution
(1 0 0  p i 
supernatant)
42006 37710 39515 36445 26690 28375 26480 26624
Receiving
solution
(100  p i 
supernatant)




Notes. The time indicates when 100 pi aliquots were removed from the feed solution

















T i me  (hour)
Figure 3.26 Transport o f BSA as a function of time with the PPy/CB membrane as
described in Table 3.15.
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The data presented in Table 3.15 and Figure 3.26 show that BSA slowly migrated 
through the membrane under the conditions of the experiment. Direct counting of the 
membrane at the end of the experiment gave a value of 85961 CMP representing 1.1% 
of the total BSA. After 25 hrs approximately 1.2 x 106 CPM (16% of total BSA) had 
migrated from the feed to receiving solution, far more than was bound to the membrane.
A comparison of the behavior of the three different membranes used for the 
transport experiments is shown in Table 3.16. Little difference is seen between 
membrane pTS or BD counterions, however the membrane with CB counterion both 
bound more protein and allowed significantly more protein transport. While the 
explanation for this is not obvious, perhaps a steric influence of the dextran (of Blue 
Dextran) partially inhibits transport in this case.
Table 3,16 A Comparison o f the three different PPy membranes used for the transport 
experiments.
Membrane % BSA bound to % BSA transport to
the membrane the receiving solution




To determine whether the BSA bound to the membrane during the transport 
experiment could be released by reversing the potential (+ 1.5 V), the PPy/CB
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membrane used in the transport experiment was returned to the transport cell after 
gamma counting. A release experiment was then carried out overnight with reversed 
potential. The results are shown in Table 3.17. They show that BSA was released from 
the membrane into both compartments. However, release into the feed solution 
predominated as expected. A total of 1.2 x 105 CPM was released showing that this 
process was essentially quantitative.
Table 3.17 BSA removal from PPy/CB membrane.
Feed solution
200 p i supernatant, CPM
Receiving solution
200 p i supernatant, CPM
1112 572
Notes. After the BSA transport experiment the PPy/CB membrane was returned to the 
transport cell; 15 ml o f 0.05 M  phosphate buffer (pH 7.5) was used as the feed and 
receiving solution. A constant potential o f + 1.5 was applied. After standing overnight 
200 pi from each side was counted.
3.3.7.2.4 OVA transport using constant potential control with the PPy/CB 
membrane
The experiment was carried out as described for the comparable experiments with 
BSA. Both the feed and receiving solution consisted of 15 ml 0.05 M phosphate buffer 
(pH 7.5) but, to the feed solution, 2.6 x 10'5 mg/ml 125I-OVA (3.4 x 106 CPM) was 
added. A constant potential of — 1.5 V vs Ag/AgCl was applied. 100 pi of supernatant 
from each side was taken for counting at various intervals (Figure 3.27).
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Figure 3.27 Transport o f OVA with PPy/CB membrane as a function o f time. 
Conditions are same as described in Table 3.15.
This experiment was terminated by an instrument malfunction that cut off the 
applied voltage after 5 hrs. The results show that after 5 hrs with an applied potential of 
-  1.5 V vs Ag/AgCl, 14% of the OVA had migrated from the feed solution to the 
receiving solution which can be compared with transport of 3% of BSA for the sane 
period. Because of the malfunction the amount of OVA bound to the membrane could 
not be compared with the comparable value for BSA.
However, the membrane could still be utilized for a release experiment and this 
was carried out exactly as for BSA (see page 104). The results (Table 3.18) show that 
less than 5% of the OVA was released and that there was no preferential direction of
migration.
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Table 3.18 OVA removalfrom PPy/CB at a constant potential o f i 1.5 V
Feed solution
200 p i supernatant, CPM
Receiving solution
200 p i supernatant, CPM
467 447
Notes. Conditions are same as described in Table 3.17.
3.4 CONCLUSIONS
The aim of the experiments described in this chapter was to investigate the 
binding and release of the model proteins, BSA and OVA, to composite PPy 
membranes incorporating the dyes, CB and BD. The membranes were prepared 
electrochemically and characterised by XPS, CV and SEM. Based on preliminary 
experiments using a column of CB-agarose to study the chromatographic behaviour of 
the same proteins, it was expected that BSA would bind strongly to the composite 
membranes, while OVA would not. It was further expected that bound proteins would 
be eluted by buffers of high ionic strength.
Radio-labelled proteins were used to monitor the binding and release of both 
model proteins with composite membranes formed on platinised PVDF. It was found 
that both BSA and OVA bound to these membranes with the binding of OVA being 
significantly greater; however, both proteins also bound to the control membrane, 
PPy/pTS (see Table 3.3 and Figure 3.8). Using OVA alone, results were obtained that 
suggest that the platinised surface of the underlying PVDF membrane was responsible 
for much of this binding (Figure 3.9). Protein binding was also strongly increased by
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pre-wetting the membrane (Figure 3.10), the time of binding, and the protein 
concentration in the binding solution (Figure 3.11).
Membrane electrodeposited on stainless steel rather than platinised PVDF were 
found to bind much less protein, however, again the binding of OVA was greater than 
that of BSA (Figure 3.18). A similar result was found when free-standing membranes 
were used to study binding (Figure 3.19).
The experiments summarised above suggest that the binding of the model 
proteins to the membranes studied is largely non-specific, perhaps driven by 
hydrophobic forces. There is little evidence for an influence of specific binding 
between the dye, CB and BD, and BSA on the overall binding of this protein.
In general, little of the protein bound to these membranes was released by 
incubation in buffer of high ionic strength (1 M salt). However, as shown in Figure 
3.17, the release of BSA from the membranes, PPy/CB and PPy/BD, was significantly 
greater than that from the membrane PPy/pTS; perhaps this is an indication of some 
influence of these dyes on the binding of BSA.
Experiments to measure the transport of the same two radio-labelled model 
proteins through PPy membranes showed that, again, there was some slight binding to 
the membrane in the transport cell (Table 3.11 ~ 3.15). The membrane, PPy/CB, both 
bound more BSA and allowed more transport to the receiving solution. This may be 
due to the specific interaction between the dye and BSA; though it is not obvious why 
the same interaction was not found with the membrane, PPy/BD (see Table 3.16).
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CHAPTER 4 PPY/HEPARIN SYSTEM IN PROTEIN SEPARATION
4.1 INTRODUCTION
Thrombin purification by Heparin-Sephadex affinity chromatography has long been 
used. In this chapter, heparin was incorporated into polypyrrole coated on Pt/PVDF/Pt 
substrates or RVC. The coated substrates were studied following the affinity separation 
procedures. Thrombin binding and release with PPy/Heparin membranes was investigated 
in detail either by soaking or using electrochemical control. Trypsin binding and release 
using PPy/Heparin coated substrates was also undertaken.
4.2 EXPERIMENTAL
4.2.1 Chemicals and Materials
Pyrrole obtained from Merck was purified by fractional distillation at 130 °C and 
stored below -18 °C under argon. Heparin, sodium salt, from porcine intestinal mucosa
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was from Sigma, H 3393, with an activity of 170 USP unit/mg. Low molecular weight 
heparin (Sigma) of Mwt 3000 (H 3400) and Mwt 6000 (H 2149) was also used. Toluidine 
Blue kindly supplied by Division of Molecular Science (DMS), CSIRO was used to assay 
heparin. Thrombin from bovine plasma was used (Sigma, T 4648). Thrombin specific 
substrate (T-1637), N-p-Tosyl-Gly-Pro-Arg-p-nitroanilide, acetate salt from Sigma was 
employed as well. Trypsin (Sigma) was obtained from DMS, CSIRO. The trypsin 
specific substrate, benzoyl-DL-arginine-p-nitroanilide (DL-BAPA, or BAP A) was 
obtained from Sigma. Heparin agarose from Sigma (B 4875) was used in the control 
experiments for thrombin and trypsin affinity separation. Bio-Rad Poly-Prep 
chromatography columns (10 ml) were used in trypsin and thrombin affinity 
chromatography. All reagents were analytical grade unless otherwise stated. Milli-Q 
water purified to 18 MQ cm was used in preparation of aqueous solutions.
Millipore polyvinylidene fluoride (PVDF) membrane (type GVHP) with nominal 
0.22 pm pore size with both sides platinised and Reticulated Vitreous Carbon (RVC) from 
ERG were used as substrates. The PVDF substrate membrane sputter coated with 
platinum has been described in Section 2.1.
4.2.2 Preparation of Polypyrrole Composite
4.2.2.1 Conducting polymer grown on platinised PVDF matrix
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The electrochemical preparation of polypyrrole was described in Section 2.2.1. In 
this study, heparin was the main counterion to be incorporated. PPy/pTS and PPy/C1 0 4  
membranes were also synthesised and served as control membranes. Polymerisation 
conditions are shown in Table 4.1.
Table 4.1 Different P P y membranes made under various polym erisation conditions.
P P y m em brane Polym erisation conditions
0.5 mg/ml heparin + 0.2 M pyrrole, 0.5 mA cm'2, 2minutes
0.5 mg/ml heparin + 0.2 M pyrrole, 0.5 mA cm'2, 4minutes
0.3 mg/ml heparin + 0.2 M pyrrole, 0.5 mA cm'2, 2minutes
PPy/Hep 0.3 mg/ml heparin + 0.2 M pyrrole, 0.5 mA cm'2, 4minutes ***
0.3 mg/ml heparin + 0.2 M pyrrole, 62.5 pA cm ', 16minutes
0.3 mg/ml heparin + 0.2 M pyrrole, 62.5 pA cm ', 32minutes
0.1 mg/ml heparin + 0.2 M pyrrole, 0.5 mA cm'2, 2minutes
PPy/pTS 0.05 M pTSNa + 0.2 M pyrrole, 0.5 mA cm'2, 4minutes ***
PPy/C104 0.5 M NaC104 + 0.5 M pyrrole, 0.5 mA cm'2, 4minutes
Notes. The area o f  each PP y membrane was 16 cm . The membrane preparations were 
carried  out by galvanostatic polym erisation a t the current density fo r  the times shown 
above. ***: PP y membranes p repared  with these conditions were used in the PPy/Hep- 
trypsin (or thrombin) system studies (unless otherwise stated).
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4.2.2.2 Conducting polymer grown on RVC
Preparation of polypyrrole on RVC was also carried out using the method described 
in Section 2.2.2. PPy/heparin/RVC was studied as the major focus, while PPy/pTS/RVC 
was employed as control membrane for study. The PPy membranes used in PPy/Hep- 
trypsin studies were prepared as described in Table 4.2.a, and the PPy membranes used in 
PPy/Hep-thrombin studies were prepared as described in Table 4.2.b.
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Table 4.2.a  Polym erisation conditions used to coat RVC fo r  use in PPy/Hep-trypsin  
studies.
P P y/R V C Polym erisation conditions
PPy/Hep/RVC 0.3 mg/ml heparin + 0.2 M pyrrole, constant current of 
8 mA, 15 minutes
PPy/pTS/RVC 0.05 M pTSNa + 0.2 M pyrrole, constant current of 
8 mA, 8 minutes
Notes. Polym erisation w as carried  out using galvanostatic control.
Table 4.2.b Polym erisation conditions used to coat RVC, fo r  use in PPy/Hep-thrombin 
studies.
PPy/H ep/R V C polym erisation conditions
PPy/Hep/RVC 0.1 M pyrrole + 0.01% unfractionated heparin (Hep), 
constant current of 8 mA for 8 minutes.
PPy/Hep6ooo/RV C 0.1 M pyrrole + 0.01% heparin, Mwt of 6000 (Hep6ooo), 
constant current of 8 mA for 8 minutes.
PPy/ Hep3ooo/RV C 0.1 M pyrrole + 0.01% heparin, Mwt of 3000 (Hep3ooo), 
constant current of 8 mA for 8 minutes.
PPy/pTS/RVC 0.05 M pTSNa + 0.2 M pyrrole, constant current of 
8 mA for 8 minutes
Notes. Polym erisation was carried out using galvanostatic control.
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4.2.3 X-ray Photoelectron Spectroscopy (XPS)
Surface elemental analysis was carried out by XPS according to Section 2.4. The 
elements, C, O, S and N were detected and quantitated. As described in Section 1.2.4, 
heparin is composed of repeating units of disaccharide, so the mole ratio of disaccharide 
units in heparin to pyrrole was used as the heparin incorporation level. Based on the 
molecular formula of pyrrole (C4H5N) and the structure of the major disaccharide unit in 
heparin (Figure 1.7), this mole ratio was calculated using the Equation 4.1.
s%x-4
.......( 4 . , )
Hepu refers to the disaccharide unit o f  heparin.
4.2.4 Cyclic Voltammetry (CV)
The redox properties of PPy/heparin membrane were studied using cyclic 
voltammetry (CV). Cyclic voltammograms were obtained using the method described 
previously in Section 3.2.4.
4.2.5 Heparin Assay —  Toluidine Blue Method
The amount of heparin in solution and incorporated into polypyrrole composite 
membranes was measured using the Toluidine Blue (TB) method, as described in Section
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2.11. This method involved detecting the dye removed from the supernatant at 631 nm as 
Toluidine Blue is adsorbed onto the sulfate groups of heparin.
Two techniques were used to determine the amount of heparin incorporated into the 
membrane. The first involved estimation of the heparin concentration in the 
polymerisation mixture before and after membrane polymerisation. The Toluidine Blue 
assay was used to measure the heparin concentration using 200 pi aliquots of 
polymerisation mixture before and after polymerisation. It was also used to directly 
measure the heparin content of the membranes. The procedures used were as follows. 
PPy/heparin membranes were cut into small squares in 0.6 cm x 0.6 cm. Each of the small 
squares was then soaked in 50% ethanol for 15 minutes and rinsed thoroughly with 
distilled water prior to the Toluidine Blue assay. The assay was then carried out as 
described in Section 2.11.
4.2.6 Trypsin Activity Assay-----Using Specific Substrate, BAPA
Both trypsin and thrombin are serine proteinase. Trypsin is much cheaper than 
thrombin, and so was used in a number of experiments.
To detect trypsin activity, a chromogenic substrate for trypsin, DL-BAPA, as 
described in Section 2.12 was employed. A trypsin standard curve covering the range 0 ~
160 pg trypsin was prepared.
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4.2.7 Thrombin Assay-----Using Thrombin Substrate, T-1637
Thrombin was assayed, as described in Section 2.13, using thrombin substrate, N-p- 
Tosyl-Gly-Pro-Arg-p-nitroanilide (T-1637). In this chapter, two thrombin standard curves 
were prepared using 30 pM and 20 pM of thrombin substrate.
Standard curve 1 was prepared using 30 pM thrombin substrate. 2 ml of 30 pM 
thrombin substrate solution was pipetted into each of 5 test tubes, varying amounts of 
thrombin, 0 pg ~ 9 pg, were added and mixed well. Then the solution in each tube was 
incubated at room temperature for 10 minutes. After that, 500 pi of 20% acetic acid was 
added into each tube to stop the reaction. In a 3 ml cuvette, the absorbance was then 
measured at 410 nm.
Standard curve 2 was prepared using 20 pM thrombin substrate as follows: 1 ml of 
20 pM thrombin substrate solution was pipetted into each of 9 test tubes, with varying 
amounts of standard thrombin (0 pg ~ 1.5 pg) added, then mixed well and incubated at 
room temperature for 20 minutes. After that, 150 pi 20% acetic acid was pipetted into 
each tube to stop the reaction. In a 1 ml cuvette, the absorbance was measured at 410 nm.
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4.2.8 Chromatography on a Heparin-Agarose Affinity Column
4.2.8.1 Chromatography on a Heparin-agarose affinity column: trypsin separation
A small column was packed with 1 ml of Heparin-agarose, and equilibrated with 5 
ml of buffer A (0.05 M sodium citrate, pH 3.0). Following this, 200 pi of 1 mg/ml trypsin 
in buffer A was loaded onto the column, which was then washed with 3.2 ml of buffer A; 
400 pi of fractions were collected. The column was then eluted with 4.0 ml of buffer B (1 
M NaCl in buffer A). 500 pi fractions were collected and the trypsin activity assayed 
using DL-BAPA.
4.2.8.2 Chromatography on Heparin-agarose affinity column: thrombin separation
A small column packed with 1ml of Heparin-agarose was equilibrated with 5 ml of 
buffer TL (0.11 M sodium chloride, 0.03 M tri-sodium citrate, 0.01 M sodium di-hydrogen 
orthophosphate, 0.025 M di-sodium hydrogen orthophosphate, pH 7.5). Then 200 pi of 1 
mg/ml thrombin in Milli-Q water was loaded onto the column, and washed with 2.4 ml of 
buffer TW (0.25 M sodium chloride, 0.02 M Tris, pH 7.5); 400 pi of each fraction was 
collected. Following this, the column was eluted with 2.8 ml of elution buffer TE (1 M 
NaCl with 0.01 M tris, pH 7.5), and 400 pi of each fraction was collected. Finally, 0.8 ml 
of 4 M NaCl was added and 400 pi of each fraction was obtained. Thrombin assay on
each fraction was carried out.
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4.2.9 Trypsin Binding and Release with PPy/Heparin Coated Substrates by Soaking
Trypsin is very stable at pH 3.0. At this pH, it can be stored at 0 ~ 5 °C for several 
months. However, when the pH is lower than 3.0, trypsin is easily denatured. When the 
pH is higher than 5.0, trypsin readily autolyses and loses its activity [113]. Thus pH 
control at 3.0 is very important. In order to determine whether heparin incorporated into a 
polypyrrole membrane still binds trypsin, a simple experiment was carried out as follows 
using PPy/heparin deposited on either Pt/PVDF/Pt or RVC. The PPy coated substrates 
were equilibrated with buffer A (0.05 M sodium citrate, pH 3.0) and incubated with 
various amounts of trypsin at 4 °C. The samples were then washed thoroughly with buffer 
A and the trypsin bound determined by measurement of activity using DL-BAPA. The 
release of trypsin from the samples was studied by incubating the samples after trypsin 
treatment with buffer B (1 M NaCl in buffer A, pH 3.0). All binding and release 
experiment were carried out with gentle shaking. PPy/BD, PPy/pTS, PPy/C1 0 4  and plain 
Pt/PVDF/Pt or RVC served as control membranes in the binding and release study.
4.2.10 Thrombin Binding and Release with PPy/Heparin Coated Substrates by 
Soaking
The main steps of PPy-thrombin affinity separation are shown in Figure 4.1.
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Equilibration o f PPy!Hep 
sample with Buffer TL
Preincubation o f sample 
with BSA
Incubation o f sample in 
a certain concentration 
o f thrombin
Non-specific elution 
by Buffer TW r
A









To block the non-specific 
binding sites
To remove the non-adsorbed 
thrombin, non-specifically 
adsorbed or low-affinity binding 
thrombin
To separate various To remove tightly 
sp e cifically b ound b ound thrombin,
thrombin
F igure 4.1 Steps o f thrombin binding and release with PPy/heparin coated substrates by 
soaking. Thrombin activity was measured after each step.
The PPy/Hep coated substrates were equilibrated with buffer TL, the equilibration 
buffer, then the samples were pre-incubated in BSA to remove some non-specific binding. 
Following this, the samples were incubated in a certain concentration of thrombin. The 
next step was to wash them with buffer TW, the washing buffer, to remove the non- 
adsorbed protein. Specific elution was carried out using buffer TE, the elution buffer. By 
this step, the bound thrombin was eluted, and possibly, through the use of stepwise or 
gradient elution, various specifically bound thrombins could be separated. Finally, 4 M 
NaCl was used to remove the strongly bound thrombin. All binding and release 
experiments were carried out with gentle shaking.
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4.2.11 Trypsin and Thrombin Binding and Release with PPy/Heparin Coated 
Substrates using Electrochemical Control
To study the PPy/heparin membrane on Pt/PVDF/Pt, the 60 ml electrochemical 
transport cell described in Section 2.3 was employed. In the study of PPy/heparin on 
RVC, the experiment was carried out in a three-electrode cell. Two same size of 
PPy/heparin/RVC served as working and counter electrode, respectively; a Ag/AgCl (3 M 
NaCl) was used as the reference electrode. Electrochemical control by constant potential 
was used in this study.
4.3 RESULTS AND DISCUSSION
4.3.1 PPy/Heparin Synthesis and Preliminary Characterisation
PPy/heparin membrane was readily deposited onto the anode by electrochemical 
oxidation. Coating of PPy/heparin on RVC posed the same problems as discussed in 
Section 3.3.1.2, in that the polymer did not grow throughout the RVC, but was restricted to 
the surface.
4.3.1.1 Determination of the amount of heparin incorporated into PPy membranes
The PPy/heparin and PPy/C104 membranes produced were analysed by XPS and the 
Toluidine Blue assay. The XPS results are shown in Table 4.3.
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Table4.3 X PS results fo r  PPy/heparin membranes p rep a red  under different polym erisation  
conditions together with result on control membrane, PPy/C l04.




0.5 mg/ml Hep + 0.2 M Py, 0.5mA cm'2, 
4 minutes
21.91 64.27 2.87 10.94 1:10.4
PPy/Hep 
Sam ple 2
0.5 mg/ml Hep + 0.2 M Py, 0.5mA cm'2, 
2 minutes
22.35 65.41 2.64 9.61 1:9.9
PPy/Hep 
Sam ple 3
0.5 mg/ml Hep + 0.2 M Py, 0.5mA cm"2, 
4 minutes
21.75 65.14 2.57 10.54 1:11.3
PPy/Hep 
Sam ple 4
0.3 mg/ml Hep + 0.2 M Py, 0.5mA cm'5, 
2 minutes
24.58 63.51 2.75 9.16 1:9.0
PPy/Hep 
Sam ple 5
0.3 mg/ml Hep + 0.2 M Py, 0.5mA cm'2, 
4 minutes
25.74 60.85 3.07 10.34 1:9.1
PPy/Hep 
Sam ple 6
0.1 mg/ml Hep + 0.2 M Py, 0.5mA cm'2, 
2 minutes
21.42 66.51 2.45 9.61 1:10.9
PPy/C104 0.5 M NaC104+ 0.5 M Py, 0.5mA cm'2, 
4 minutes
25.84 64.56 0.16 9.44
Notes. In these results, % referred to atomic cone. %. H epu refers to the disaccharide o f
the heparin.
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The results from Toluidine Blue assay are shown in Table 4.4. These results are 
quantitatively the same as those from XPS analysis (Table 4.3). The range of heparin 
incorporated into PPy was about 18.9-28 pg cm'2, more than has been reported previously 
(1~5 ng cm'2) [44],
Table 4.4 Heparin assay results on PPy membranes by Toluidine Blue method
Sample OD631 nm Hep, fig
PPy/Hep, Sample 1 0.44 6.8
PPy/Hep, Sample 2 0.43 6.9
PPy/Hep, Sample 3 0.46 -
PPy/Hep, Sample 4 0.41 10.1
PPy/Hep, Sample 5 0.42 8.2




Notes. The absorbance at 631 nm o f Toluidine Blue (TB) solution served as control Each
sample was 0.6 cm x 0.6 cm.
The incorporation of heparin into polypyrrole membranes was also determined by 
assaying the heparin remaining in the polymerisation solution after membrane formation 
under various conditions. The results are presented in Figure 4.2 and Table 4.5. The 
results show that the amount of heparin incorporated was greater when the polymerisation
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was carried out using low current density for longer times rather than high current d e n s it y  
for shorter times. The explanation for this result is discussed in Section 33.1.1. 
However, previous workers reported that the heparin incorporation, as measured b y  th e  













Before 0.5 mA/cm2 0.5 mA/cm2 62.5 ^A/cm? 62.5̂ A/cm2 
synthesis 2 min 4 min i6min 32 min
Polymerisation conditions
Figure 4.2 Effect o f current density applied during polymerisation. Heparin assay 
showing removal from the polymerisation solution during electrochemical synthesis.
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Table 4.5 Heparin incorporation under different polymerisation conditions.












polymerisation with 0.5 mA/cm , 
4 minutes
(200 pi supernatant)
0.31 0.25 mg 5.6 ng
After galvanostatic 
polymerisation with 62.5 pA/cm , 
32 minutes 
(200 pi supernatant)
0.38 0.43 mg 9.7 ng
0 pi supernatant 
(TB solution)
0.58
4.3.1.2 Cyclic voltammetry of PPy/heparin films
A PPy/heparin film was grown on a Pt disk, the area of which was 0.018 cm2, using 
a solution containing 0.3 mg/ml heparin in 0.2 M pyrrole, and a current density of 2 mA 
cm'2 applied for 1 minute. Cyclic voltammetry was carried out at this PPy/heparin/Pt 
modified electrode in a three-electrode cell as described in Section 2.6, and the results are 
shown in Figure 4.3.
Figure 4.3.a shows that the PPy/heparin film was electroactive and there were two 
redox couples in this cyclic voltammogram. The redox couple A/B was due to the electro­
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activity of PPy/heparin, whereas redox couple C/D was due to K3Fe(CN)6. This was 
confirmed from the cyclic voltammogram of K3Fe(CN)6 at a bare Pt disk electrode, and 
CV of PPy/heparin/Pt in NaCl alone (results not shown). The CV of PPy/heparin film 
(Figure 4.3.b) in 0.05 M phosphate buffer (pH 7.5) shows one broad oxidation peak and 
one reduction peak. Both cyclic voltammograms show that PPy/heparin membrane was 
electroactive.
Figure 4.3.a Cyclic voltammogram ofPPy/Hep in 2 x  10 3MKsFe(CN)6 with 0.1 M  
NaCl. Scan rate: 100 mV s'1.
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Figure 4.3.b Cyclic voltammogram ofPPy/Hep in 0.05M  phosphate buffer, pH 7.5. Scan 
rate: 50 mV s'1.
4.3.2 Chromatography on Heparin-Sephadex Affinity Column
4.3.2.1 Trypsin separation using Heparin-agarose affinity column
Figure 4.4 shows the elution profile for chromatography of trypsin on the Heparin- 
Agarose column. The result showed that trypsin binds to Heparin- agarose and is eluted 
by higher ionic strength using 1M NaCl.
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Figure 4.4 The elution profile of trypsin from a Heparin-agarose affinity column (1 ml). 
200 pi o f 1 mg/ml trypsin in buffer A (0.05 M  sodium citrate, pH 3.0) was loaded. 
Fraction 1-8 were washed with buffer A; each fraction was 400 pi. Fraction 9-16 were 
eluted with buffer B (1 MNaCl in buffer A); each fraction was 500 pi. Trypsin activity of 
each fraction was detected using DL-BAPA.
4.3.2.2 Thrombin separation using Heparin- agarose affinity column
The thrombin activity result in Figure 4.5 shows thrombin separation using Heparin- 
agarose affinity column. It was found that thrombin mostly bound on the column and was
released by 1 M NaCl.
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Figure 4.5 The elution profile of thrombin from Heparin-agarose affinity column (1 ml). 
200 pi o f 1 mg/ml thrombin in Milli-Q water was loaded. Elution under gravity was with 
buffer TW (fraction 1~6), buffer TE (fraction 7-13) and finally with 4 M  NaCl. Each 
fraction was 400 pi. Thrombin activity of each fraction was measured using thrombin 
assay.
Notes. The maximum value possible for thrombin activity assay under this conditions was
OD 410 nm= 0.16.
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The results of the chromatography experiments with trypsin and thrombin on 
Heparin-agarose will be compared with the results from binding and release on 
PPy/heparin membranes in further sections.
4.3.3 Trypsin Binding and Release Experiments by Soaking
4.3.3.1 Trypsin binding and release with PPy/Hep/Pt/PVDF/Pt membranes
A preliminary experiment was carried out to test the binding and release of trypsin 
from PPy/Hep membranes. Several PPy/Hep membranes of 10 cm2 were cut into small 
squares, soaked in 50% ethanol for 15 minutes, then washed with Milli-Q water 
thoroughly. The membrane samples were equilibrated with buffer A (0.05 M sodium 
citrate, pH 3.0) for 1 hr, then incubated in 1 ml trypsin solution (0.2 mg/ml in buffer A) 
overnight at 0-5 °C. After this time the membranes were assayed directly for trypsin 
activity using BAP A. The results are shown in Figure 4.6 which shows an increase in 
trypsin activity on all these heparin-containing membranes compared to a control 
membrane, Pt/PVDF/Pt.
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Figure 4.6 Trypsin binding on PPy/heparin membranes and the control sample. PPy/Hep- 
1 was prepared in 0.1 mg/ml heparin with 0.2 Mpyrrole, with a current density o f 0.5 mA 
cm' applied for 2 minutes. PPy/Hep-2 was prepared in 0.3 mg/ml heparin with 0.2 M  
pyrrole, with a current density o f 0.5 mA cm 2 applied for 4minutes. PPy/Hep-3 was 
prepared in 0.3 mg/ml heparin with 0.2 M  pyrrole, with a current density o f 0.5 mA cm 2 
appliedfor 2minutes. Pt/PVDF/Pt membrane served as control in this experiment.
After carrying out the trypsin assays, the membrane samples were incubated in 
buffer B (1 M NaCl in buffer A) for 2 hrs. The membranes and the supernatant were 
assayed for trypsin activity. The results are shown in Table 4.6 which shows that little 
activity was found remaining on the membranes but no activity was found in the
supernatant.
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PPy/Hep-1 0.15 0.02 0.00
PPy/Hep-2 0.14 0.01 0.00
PPy/Hep-3 0.17 0.02 0.00
Pt/PVDF/Pt 0.08 0.00 0.00
Notes. BAP A assay was carried out on both the membranes and supernatant.
The experiment was carried out a second time using PPy/Hep, Pt/PVDF/Pt and 
PPy/pTS membranes. Squares (0.4 cm x 0.4 cm) of each membrane was soaked in 50% 
ethanol for 15 minutes, washed with Milli-Q water and equilibrated with buffer A for 1 hr. 
They were then incubated in 0.7 ml of 0.5 mg/ml trypsin in buffer A for 3 hrs. The 
membrane squares were then assayed for bound trypsin activity with BAP A, washed with 
0.05 M Tris buffer (pH 8.0) containing 0.02 M CaCl2 and the activity assay repeated. The 
results shown in Table 4.7 again show that the trypsin activity is greatest for the heparin- 
containing membrane. However, on re-assay, the activity is greatly reduced for all
membranes.
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The reason for this loss of activity is not clear, but as a result of it, the binding and 
release experiments were modified. All membranes were divided into two groups on 
which the same procedure for trypsin binding was carried out. One group, Group A, was 
used in the binding assay to determine the extent of trypsin binding. The other, Group B, 
was subjected to the release experiment, after which the bound trypsin activity was 
determined to estimate the extent of trypsin release.
The Toluidine Blue method for heparin assay was also carried out twice on the 
same membrane sample, however, there was not much absorbance change at 631 nm 
between the two assays on each sample (result not shown).
In order to investigate the possibility of re-use of membranes, the trypsin binding 
experiments were carried out twice on the same PPy membrane using the same binding 
conditions. 8 cm2 of each of the PPy/Hep, Pt/PVDF/Pt, PPy/pTS membranes were cut into 
small squares, about 0.4 cm x 0.4 cm. Each sample was pre-wetted, and equilibrated with
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buffer A for 1 hr. Binding was carried out by incubation in 0.7 ml 0.5 mg/ml trypsin for 
180 minutes. After the trypsin assay using BAP A, all membranes were washed thoroughly 
with 0.05 M Tris (pH 8.0) containing 0.02% CaCb, then incubated again in 0.7 ml of 0.5 
mg/ml trypsin for 180 minutes. The BAPA assay was carried out again to detect trypsin 
binding a second time. The results (Table 4.8) show that all the PPy membranes used for 
the second time still had similar binding capacity for trypsin. In fact, PPy/heparin 
membranes could be re-used at least 5 times (data not shown) without reduction of trypsin 
binding capacity. This result is significant for the potential use of these membranes for 
trypsin or thrombin purification.
Table 4.8 BAPA assay for trypsin binding results.
Sample Trypsin binding Trypsin binding




In order to reduce non-specific binding of trypsin to PPy/Hep membranes, a pre­
incubation step using BSA solution was used. Thus 8 cm2 of each membrane, Pt/PVDF/Pt, 
PPy/pTS or PPy/Hep, was used. Two sets of identical membranes were prepared, Group A 
and Group B, and then each set of membranes was cut into small squares of 0.4 cm x 0.4 
cm. They were pre-wetted in 50% ethanol for 15 minutes, and then washed with Milli-Q
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water. Group B was incubated with 1 ml solution of BSA (0.4 mg/ml) in 0.01 M Tris 
buffer (pH 7.4) for 3 hrs after being pre-equilibrated with the same buffer, buffer A. Both 
groups were then incubated with trypsin (0.5 mg/ml, 0.7 ml) in buffer A for 3 hrs. Trypsin 
bound was then assayed using the BAP A assay (Figure 4.7). This shows that pre­
incubation with BSA significantly reduced trypsin binding to each membrane though 
appreciable trypsin binding to the PPy/Hep membrane was still found. Thus the binding to 
this membrane was specific and mediated by the interaction of trypsin with heparin.
0  Without BSA HWith BSA
0.4 n
"  .............. — i—   i
Pt/PVDF/Pt PPy/pTS PPy/Hep
Sample
Figure 4. 7 Trypsin binding result with BSA pre-incubation. The result without BSA pre­
incubation served as control.
In order to study the release of trypsin from such membranes, two sets of identical 
PPy/Hep membranes were loaded with trypsin by incubation in a solution of trypsin (0.5 
mg/ml trypsin in buffer A) for 3 hrs. The release experiment was carried out by incubation 
of the membrane with 1M NaCl in buffer A (1 ml solution mixture) for 3 hrs. The results
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are shown in Table 4.9. For each membrane the apparent trypsin activity after treatment 
with 1 M NaCl was significantly lower than the value before treatment, showing that 
trypsin was indeed released from the membrane.
Table 4.9 Trypsin binding and release results on PPy/Hep membranes.
Sample Membrane Membrane
Before release After release
(3 hrs)
50 squares o f 0.4 cm x 
0.4 cm OD410 nm OD4i0nm
PPy/Hep - 1 0.38 0.12
PPy/Hep -  2 0.18 0.10
PPy/Hep - 3 0.38 0.14
Notes. Trypsin activity remaining in membranes was measured using BAP A assay.
4.3.3.2 Use of PPy/Hep/RVC for Trypsin binding
PPy/Hep/RVC was prepared as described in Table 4.2.a. Cubes of 5 x 5 x 3 mm 
PPy/Hep/RVC were pre-wetted with 50% ethanol for 15 minutes and equilibrated in buffer 
A (0.05 M sodium citrate, pH 3.0) for 1 hr. Uncoated RVC, 5 x 5 x 3 mm served as 
control. They were then incubated in 1 ml of 0.1 mg/ml trypsin in the same buffer for
various times.
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The results are shown in Figure 4.8. It can be concluded that more trypsin bound to 
the heparin-containing PPy coated RVC than to uncoated RVC, and the amount bound 
increased with time. It is not clear why the amount bound after 5 hrs is greater than that 
bound after overnight incubation though it could be due to denaturation of trypsin or 
changes to the PPy/heaprin by prolonged incubation at pH 3.0. The overnight incubation 
was carried out in triplicate and gave identical results for each sample.
Figure 4.8 Trypsin binding with different binding duration.
To study the effect of trypsin concentration on binding, three portions of 
PPy/Hep/RVC, 5 x 5 x 3  mm, were prepared, pre-wetted with 50% ethanol for 15 minutes, 
rinsed thoroughly with water and then equilibrated with buffer A for 1 hr. Each of the 
RVC portions was incubated in 1 ml trypsin solution of different concentrations for 3 hrs. 
As for BSA and OVA binding (Section 3.3.1.1), trypsin binding also improved with 
higher concentrations of trypsin used in the binding solutions (Figure 4.9). The amount
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bound increased with the trypsin concentration but appeared to level off at around 0.25 
mg/ml, possibly due to the membranes being saturated with trypsin.
Figure 4.9 The effect o f different concentrations o f trypsin on trypsin binding.
4.3.4 Trypsin Binding and Release with Electrochemical Control
4.3.4.1 Trypsin binding and release under electrochemical control on
PPy/Hep/Pt/PVDF/Pt membranes
A series of experiments were carried out to evaluate the effect of electrical potential 
on binding and release of trypsin to/from PPy/Hep membranes.
A PPy/Hep membrane was installed in the 60 ml transportation cell described in 
Section 2.3; the membrane area contacting the solution in this cell was 5 cm . The
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membrane was pre-wetted with 50% ethanol for 15 minutes, and rinsed thoroughly with 
water, and then incubated in 0.05 M sodium citrate, (pH 3.0, buffer A) for 1 hr. 0.1 mg/ml 
trypsin in buffer A was then introduced into the feed side, while buffer A was added into 
the receiving solution.
Aliquots of 2 0 0  pi were removed from the feed solution for assay at zero time, after 
60 minutes with Eapp = -  0.5 V vs Ag/AgCl applied and after a further 60 minutes with 
Eapp = + 0.5 V vs Ag/AgCl applied. Finally the membrane itself was rinsed with buffer A 
and assayed. Assay results for the aliquots removed and for the membrane are shown in 
Table 4.10. It is apparent that there is little depletion of trypsin from the feed solution 
following application of a negative potential, but a significant depletion after application of 
a positive potential. Trypsin was bound to the membrane during this experiment though 
the amount bound was not significant, i.e. OD410 nm = 0.38 for the entire membrane vs 
OD4iomn = 0.60 for a 2 0 0  pi aliquot from a total of 60 ml.
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Table 4,10 Trypsin binding under electrochemical control
OD410 nm
200 pi supernatant
Initial trypsin solution 0.71
After applying - 0.5 V for 1 hr 0.70
After applying + 0.5 V for 1 hr 0.60
PPy/Hep (membrane) 0.38
Notes. PPy/Hep membrane was grown on Pt/PVDF/Pt substrate in a solution o f 0.3 
mg/ml heparin and 0.2 Mpyrrole, using constant current density o f 0.5 mA cm2 for 5 
minutes.
The experiment was repeated using a series of changes from positive to negative 
potential as shown in Table 4.11. This gave essentially the same result as that presented in 
Table 4.10 in that trypsin was consistently depleted from the feed solution under the 
influence of positive potential. Applied negative potential, in general, lead to a reversal of 
transport and an increase in trypsin concentration in the feed solution.
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Table 4.11 Trypsin binding on PPy/Hep membrane under electrochemical control
Eapp Duration OD410 nm Difference in OD^onm
su pern atan t
Initial trypsin solution 0 0.69 -
-0.5 V 1 hr 0.62 -0.07
+0.5 V 3 hr 0.57 -0.05
-0.5 V 1 hr 0.58 + 0.01
+0.5 V 16 hrs 0.51 -0.07
-0.5 V 3 hr 0.55 + 0.04
-0.4 V 1 hr 0.55 -
-0.7 V 2 hr 0.59 + 0.04
+0.7 V 16 hrs 0.50 -0.09
Notes. Aliquots o f 150 pi were removed from the feed solution at different times and 
assayed using BAPA. The PPy/Hep membrane was prepared as described in notes to 
Table 4.10.
A control experiment was carried out similar to the study on PPy/Hep membrane 
using a PPy/pTS membrane. This was pre-wetted and equilibrated in buffer A for 1 hr 
before being installed in the 60 ml transport cell. 0.1 mg/ml trypsin in buffer A was then 
introduced into the feed side, while Buffer A was added into the receiving solution. The 
results are presented in Table 4.12. In this case there was no obvious change in the trypsin
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concentration in the feed solution with either positive or negative potential applied. Very 
little trypsin was found to bind to the membrane (Compared with the results in Table 4.10).
Table 4.12 Trypsin binding on PPy/pTS under electrochemical control.
Duration OD410 nm Difference in OD^onm
supernatant
Initial trypsin solution 0 0.49 -
-0.5 V 1 hr 0.53 + 0.04
+0.5 V 4 hrs 0.55 + 0.02
-0.5 V 1 hr 0.54 -0.01
PPy/pTS (membrane) 24 hrs 0.03 -
Notes. The PPy/pTS membrane was prepared as described in Section 4.2.2.1. Aliquots o f 
150 p i were removedfrom the feed solution at different times and assayed using BAP A.
4.3.4.2 Trypsin binding and release with PPy/Hep/RVC under electrochemical 
control
A similar series of experiments was carried out using PPy/Hep coated RVC. 
PPy/Hep was electrochemically deposited on RVC as described in Section 4.2.2.2. Three 
groups of coated RVC, cut into portions of 5 x 5 x 3 mm, were used with the experimental 
set-up in a 10 ml three-electrode cell. Figure 4.10 shows the results of a series of 
experiments in which the PPy/Hep/RVC portions were incubated in trypsin solution in
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buffer A for various times either with or without applied potential. In each case, trypsin 
binding to the membrane was increased with a negative potential applied and was minimal 
with a positive potential applied. This can be seen by comparison of the bound activity for 
sample 3 (no applied potential), 4 (negative potential applied) and 5 (positive potential 
applied). In fact, application of a positive potential inhibits binding to the PPy/Hep
membrane.
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Figure 4.10 Trypsin binding to PPy/Hep/RVC under electrochemical control. Trypsin 
activity remaining on each PPy/Hep/RVC was detected using BAP A.
(1) Trypsin binding by incubating in 0.1 mg/ml trypsin with no applied potentialfor 3 hrs;
(2) Trypsin binding with 0.1 mg/ml trypsin by Eapp= constant - 0.3 Vfor 2 hrs;
(3) Trypsin binding by incubating in 0.3 mg/ml trypsin with no applied potentialfor 1 hr;
(4) Trypsin binding with 0.3 mg/ml trypsin by Eapp= constant -0 .4V for 1 hr;
(5) Trypsin binding with 0.3 mg/ml trypsin by Eapp= constant + 0.6 Vfor 1 hr;
(6) Trypsin binding by incubating in 0.3 mg/ml trypsin with no applied potential for 1 hr;
(7) Trypsin binding with 0.3 mg/ml trypsin by Eapp= constant - 0.4 Vfor 1 hr.
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In the experiments described in this section, the results can, in general, be explained 
by the migration of trypsin, positively charged at pH 3.0, towards the negative electrode.
The influence of the counterion, i.e. heparin or pTS, on this behaviour is not clear. 
The results of Table 4.10 and 4.12 do show binding to the PPy/Hep membrane but not to 
the PPy/pTS membrane and this would be as expected.
4.3.5 Thrombin Binding and Release Experiments by Soaking
A series of experiments were carried out using PPy/Hep membranes to study the 
binding and release of thrombin. Three different types of heparins were used: 
unffactionated heparin (Hep) and low molecular weight heparins with molecular weight of 
6000 and 3000. These PPy/heparin coatings were deposited on platinised PVDF and on 
RVC. As previous experiments have shown that the platinum surface could lead to non­
specific binding, “double-sided” PPy membranes were prepared and tested along with 
single-sided membranes.
4.3.5.1 Thrombin binding and release with PPy/Hep/Pt/PVDF/Pt/(PPy/Hep)
4.3.5.1.1 Thrombin binding and release with “one-sided” PPy/Hep membrane
PPy/Hep membranes were deposited on one side of a Pt/PVDF/Pt substrate as 
described. PPy/pTS and the substrate Pt/PVDF/Pt were used as control membranes.
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The Toluidine Blue assay was used to determine the heparin level in each 
membrane. Results are shown in Table 4.13. The PPy/Hep contained the highest level of 
heparin sulfate groups with the PPy/Hep6ooo being intermediate and the PPy/Hep3ooo being 
lowest.
Table 4.13 Heparin assay o f  PPy/membranes.







Notes. Each sample was 25 squares o f  0.4 
described in Section 4.2.5.
cm x 0.4 cm. The assay was carried out as
A preliminary experiment was carried out to determine the stability of thrombin 
under the experimental conditions used. The results in Table 4.14 show that thrombin lost 
no activity on overnight incubation at room temperature, so that investigations into binding 
and release over this time were feasible.
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Table 4.14 Thrombin activity as a  function o f  time a t room temperature.
Incubated time 0 min 1 hr 2 hrs 3 hrs 5 hrs overnight
OD410 nm
3 ul supernatant
0.07 0.09 0.09 0.07 0.08 0.09
Notes. 1 m l thrombin solution (0.3 mg/ml in H2O) was allowed to stand a t room
temperature ; an aliquot o f  3 p i  was rem oved fo r  thrombin activity assay a t 0 hr, 1 hr, 2
hrs, 3 hrs, 5 hrs and overnight.
To study thrombin binding as a function of time, each membrane was prepared as 
described above (Table 4.13). All samples were equilibrated with buffer TL for 1 hr, then 
incubated in 1 ml BSA solution (0.5 mg/ml in Milli-Q H20) for 10 minutes and washed 
with Milli-Q H20. Following this, each sample was incubated in 1ml of thrombin solution 
(0.3 mg/ml in Milli-Q H20) for various times. They were then washed with 3 changes of 
buffer TW for 1 hr, and assayed for thrombin activity. Results are shown in Table 4.15.
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Table 4.15 Thrombin binding as a  fiinction o f  time.
Binding time Pt/PVDF/Pt PPy/pTS PPy/Hep PPy/Hep6ooo PPy/Hep3ooo
0 minute 0.03 0.01 0.01 0.00 0.01
5 minutes 0.07 0.03 0.02 0.03 0.05
30 minutes 0.06 0.02 0.02 0.01 0.03
60 minutes 0.14 0.06 0.04 0.04 0.06
120 minutes 0.12 0.05 0.04 0.05 0.07
300 minutes 0.07 0.02 0.02 0.02 0.03
2 days 0.06 0.03 0.03 0.02 0.03
.........................................  —   »-------------------------------------------------------------------- 1--------------------------------------------------  1------------------------------------------------------------- 1----------------------------------------------------j — ■
Notes. The size o f  each membrane sample was 25 swuares o f  0.4 cm x 0.4 cm (4 cm ).
Thrombin was assayed using 20 juM o f  thrombin substrate.
For all membranes the amount of thrombin bound reached a maximum after 1 ~ 2 
hrs and then declined. Maximum binding was on the Pt/PVDF/Pt membrane and this 
effect obscures any specific binding due to the heparin-thrombin interaction.
4.3.5.1.2 Thrombin binding and release with “double-sided” PPy/Hep membrane
In order to avoid the problem due to non-specific adsorption to the platinised PVDF 
surface, “double-sided” PPy membranes were prepared. The preparation was essentially 
the same as for single sided except that both sides of the platinised PVDF were deposited 
with PPy membranes as shown in Figure 4.11. Four different “double-sided” membranes
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were prepared and evaluated: pTS/pTS, Hep/Hep, Hep6ooo/Hep6ooo, Hep3ooo/Hep3ooo. They 
were polymerised under the same conditions and in the same solution as were used to 
make the one-sided PPy membranes (Table 4.13). They were cut into small squares of 0.4 
cm x 0.4 cm. 25 of these small squares were divided into one group. The Toluidine Blue 
assay, Table 4.16, showed that the Hep membrane incorporated the most heparin sulfate 
groups while the Hep3ooo membrane incorporated the least. A comparison with the results 
shown in Table 4.13 shows that more heparin is present in the double-sided than in the 
single-sided membranes, as expected.
PVDF
Platinum
Figure 4.11 Schematic diagram o f a double-sided PPy composite membrane.
Chapter 4 PPy/Heparin system in protein separation 153
Table 4 .16  Heparin assay results on double-sided PP y membranes.







Notes. Each sample was 25 squares o f  0.4 cm x 0.4 cm. Heparin assay was carried out as 
described in Section 4.2.5.
Thrombin binding as a function of time was investigated (Table 4.17) using the 
same procedure as for single-sided membranes. Again the amount of binding appeared to 
peak at around 2 hrs and then decline. An important difference between these results and 
those shown in Table 4.15 is that by using double-sided membranes thrombin binding to 
the control membrane, pTS/pTS, is almost eliminated though there is still significant 
binding to all the heparin-containing membranes. Among the heparin-containing 
membranes thrombin binding was greatest for the Hep3ooo/Hep3ooo membrane despite the 
fact that this membrane apparently contained the lowest concentration of heparin sulfate 
groups as shown by Toluidine Blue assay (Table 4.16).
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0 minute 0.00 0.00 0.00 0.00 0.00
5 minutes 0.07 0.01 0.01 0.02 0.03
30 minutes 0.13 0.01 0.02 0.02 0.06
60 minutes 0.09 0.01 0.02 0.03 0.05
120 minutes 0.12 0.01 0.03 0.04 0.11
180 minutes 0.12 0.02 0.02 0.04 0.07
o’night 0.07 0.00 0.02 0.05 0.07
An experiment to study the removal of thrombin from PPy membranes was carried 
out as follows: “double-sided” PPy membranes, pTS/pTS, pTS/Hep, PPy/Hep, Hep/Hep, 
Hep6ooo/ Hep6ooo and Hep3ooo/ Hep30oo, were synthesised and cut into a large number of 
squares of 0.4 cm x 0.4 cm. Batches of 80 squares of each type were pre-wetted and 
equilibrated in buffer TL for 1 hr with 5 changes of buffer. To reduce non-specific 
binding, they were first incubated in 1 ml of BSA solution (5 mg/ml in H2O) for 30 
minutes. They were then incubated in 1 ml of thrombin solution (0.3 mg/ml in H20) for 2 
hrs. After this, the membrane squares were washed with buffer TW for 1 hr with buffer 
changes every 10 minutes. Each batch of 80 membrane squares was then divided into two 
batches of 40, one of which was assayed directly for thrombin binding.
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The other batch of 40 was eluted with buffer TE for 1 hr to remove bound thrombin. 
The buffer was changed every 10 minutes. After this elution step, the membranes were 
then assayed for bound thrombin. The results in Table 4.18 show that, as expected from 
previous experiments, significant amounts of thrombin were bound to the membranes that 
had exposed platinum or contained heparin. In each case thrombin was released on 
washing with the buffer TE though not all the bound thrombin was removed by this 
treatment.
Table 4.18 Thrombin binding and release by soaking.
sample OD4i0nm> OD410 nm?
Binding After release for 4 hrs
pTS/pTS 0.01 0.00
pTS/ HepHep 0.02 0.01
PPy/Hep 0.07 0.03
Hep / Hep 0.04 0.02
Hepôooo/ Hepôooo 0.04 0.02
Hep3ooo/ Hepîooo 0.03 0.02
Notes. Each sample consisted o f  40 0.4 cm x 0.4 cm squares.
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4.3.5.2 Thrombin binding and release on/from PPy/Hep coated on RVC
An experiment to study the binding and release of thrombin from PPy/Hep/RVC 
was carried out. PPy/Hep/RVC was prepared as described previously (Table 4.2.2.b) and 
cut into a number of pieces of 5 x 5 x 6 mm, that were each further subdivided into two 
halves. Of these, one half would be assayed for thrombin binding and the other used for 
release. 11 pieces were used in each duplicate. They were pre-wetted and equilibrated in 
buffer TL for 2 hrs, then incubated in 1ml of thrombin (0.3 mg/ml) for 3 hrs. After 
binding, they were washed with 6 changes of buffer TW for lhr. Then one group of 11 
cubes was used for thrombin assay while the other group was eluted, by incubation in 6 
changes of buffer TE for lhr. The results are shown in Table 4.19. Thrombin was found 
to bind to all segments; for all samples the wash procedure led to a reduction in bound 
thrombin though the extent of release was quite variable. The explanation for the 
variability may be that deposition of PPy on RVC was uneven.
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Table 4.19 Thrombin binding and release result.

















Notes. The heparin used was unfractionated heparin
The degree of thrombin binding as a function of the amount of heparin deposited 
within the PPy/Hep on RVC was determined. PPy/Hep was deposited on RVC using the 
same conditions as above. After deposition the RVC was cut into many pieces of 5 x 5 x 3 
mm. Samples of 1 piece, 2 pieces and 3 pieces were chosen in this experiment. The 
amount of heparin contained in each sample was determined by Toluidine Blue assay. 
After that, all samples were incubated in 1 M NaCl for 1 hour to remove the dye, then they
were equilibrated in buffer TL overnight. Following this, they were incubated in 1ml of 
thrombin solution (0.3 mg/ml in H2O) for 4 hrs. After this binding step, they were washed 
with buffer TW for 1 hr, the buffer was changed every 10 minutes. Each sample was 
removed for thrombin assay. Results are shown in Figure 4.12, which presents the 
relationship between the amount of heparin incorporated on PPy/Hep membrane and the 
thrombin binding ability. Thrombin binding is seen to be approximately linear with the 
heparin concentration in the membrane.
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Figure 4.12 Thrombin binding as a function of the amount of heparin deposited within the 
PPy/Hep/R VC.
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Thrombin removal from these samples was also carried out. They were incubated in 
buffer TE for lhr. During this period, the buffer was changed to fresh every lOmin. The 
result (Table 4.20) shows thrombin bound on the PPy/Hep/RVC could be released by 
incubation in salt.
Table 4 .20 Thrombin binding an d  release results fo r  PPy/Hep/RVC.
PPy/Hep/RVC, OD<>31 nm, O D 410  nm, O D 410  nm,
5 x 5 x 3  mm/piece heparin contained binding after release
1 piece 0.23 0.02 0.00
1 piece 0.20 0.02 . 0.00
2 pieces 0.18 0.04 0.00
2 pieces 0.13 0.06 0.01
3 pieces 0.15 0.06 0.01
3 pieces 0.10 0.09 0.02
A further study of thrombin binding and release using PPy/Hep/RVC membranes 
was carried out using different molecular weight fractions of heparin. The polymerisation 
conditions are shown in Table 4.2.b. While Table 4.21 shows the results from Toluidine 
Blue assay of the duplicate samples. As for the membrane cast on Pt/PVDF/Pt, the highest 
number of heparin sulfate groups was found in membranes containing unffactionated
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heparin (Hep) while the least was found in membranes made with heparin of lowest 
molecular weight (PPy/Hep3ooo/RVC).
Table 4.21 H eparin assay on PPy/RVC using Toluidine Blue method.
PPy/Hep/RVC PPy/Hep6ooo/RVC PPy/Hep30oo/RVC
1 O D 631 nm 0 . 1 2 0.16 0.33
2  OÜ631 nm 0.16 0 .2 2 0.35
Notes. Each sam ple w as cut into pieces, 5 x 5  x 15 mm, pre-w etted  and then was 
conducted into heparin assay w as carried  out as described in Section 4.2.5.
Using the techniques described above, the binding of thrombin to these membranes 
was studied. Binding was carried out for two periods, 30 minutes and 3 hrs; results are 
shown in Table 4.22.
As with the PVDF-based membranes the highest level of thrombin binding, for both 
periods, was found for those membranes with low molecular weight heparin.
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Table 4,22 Thrombin binding on PPy with various molecular weights o f heparin 
incorporated.
Group No. Sample Incubation period in OD410 nm, binding
0.3 mg/ml thrombin
PPy/HEP/RVC 30 minutes 0.05
1 PPy/ Hep6ooo/RVC 30 minutes 0.06
PPy/ Hep3ooo/RVC 30 minutes 0.10
PPy/HEP/RV C 3 hrs 0.08
2 PPy/ Hep6ooo/RVC 3 hrs 0.07
PPy/ Hep3ooo/RV C 3 hrs 0.09
4.3.6 Thrombin Binding and Release Experiments using Electrochemical Control
Thrombin binding and release under electrochemical control was carried out using 
conditions similar to those used for the study of trypsin binding and release using a 10 ml 
three-electrode cell. After being pre-wetted, PPy/Hep/RVC was cut into 5 x 5 x 12 mm 
portions, and then equilibrated in buffer TL overnight. To study the effect of applied 
potential a comparison was made between binding with and without application of 
potential. One PPy/Hep/RVC portion was incubated in 10 ml thrombin solution (0.3 
mg/ml in buffer TL ) for 1 hr without potential applied, the other was incubated in 10 ml 
thrombin solution (0.3 mg/ml in buffer TL ) for 1 hr with a constant potential of - 0.3 V vs
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Ag/AgCl applied. The results are shown in Table 4.23. Significantly more thrombin was 
bound under the influence of applied potential.
Table 4,23 Thrombin binding with and without potential applied.
PPy/Hep/RVC Binding conditions Thrombin binding
OD410 nm
5 x 5 x 12 mm -0.3 V, 1 hr 0.06
5 x 5 x 12 mm soaking, 1 hr 0.02
Notes. Tapp- - 0.3 VvsAg/AgCl.
However when the potential was reversed in an attempt to release the thrombin, no 
active thrombin was released (results not shown).
4.4 CONCLUSIONS
In this chapter experiments are described which were aimed at developing a novel 
method of purification of the enzyme thrombin based on its interaction with heparin 
incorporated into PPy. This technique would be analogous to currently used thrombin 
purification by affinity chromatography on columns of heparin-agarose.
After electrochemical synthesis the extent of incorporation of heparin into the 
membranes was determined by XPS and by a chemical assay using Toluidine Blue. The
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results showed that the heparin incorporated was in the range 18 .9-28  pg/cm2 which is 
significantly higher than that obtained by previous workers (Table 4.4).
PPy membranes were prepared on both platinised PVDF and RVC. Preliminary 
experiments were carried out using trypsin as a model enzyme. Membrane bound trypsin 
could be assayed directly after binding to PPy/heparin (Figure 4.6), but it was found that a 
second assay carried out on the same membrane gave little activity (Table 4.6). The 
explanation for this loss of activity was not obvious, but it did complicate the design of 
subsequent experiments. Trypsin was found to bind non-specifically to membranes (i.e. to 
bind to membranes not incorporating heparin), but this could be largely prevented by pre­
treatment with BSA (Figure 4.7). Bound trypsin was released by treatment with buffer of 
high ionic strength (Table 4.9).
When transport experiments were carried out using these membranes, it was found 
that trypsin was depleted from the feed solution after application of a positive potential. In 
these experiments no trypsin activity could be detected in the receiving solution suggesting 
that the enzyme was binding to the membrane (Table 4.10). This behaviour was not 
evident with a control membrane (PPy/pTS) where there was no change in the trypsin 
concentration in the feed solution and little activity bound to the membrane (Table 4.12).
Similarly, binding to PPy/Hep/RVC membranes was accelerated by the application 
of a negative potential to the membrane (Figure 4.10). All these results can be explained
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by the migration of a positive charged protein molecule, trypsin, towards the negative 
electrode.
The initial experiments to measure thrombin binding to heparin-containing 
membranes were compromised by apparent non-specific binding to the platinised surface 
of single-sided Pt/PVDF/Hep membranes (Table 4.15). This effect may be similar to that 
described earlier for BSA and OVA binding to single-sided dye-containing membranes.
When both platinised surfaces were covered with a PPy membrane, this non-specific 
binding was eliminated (Table 4.17) and specific binding to heparin could be seen.
Interestingly, greater binding was found with PPy incorporating low molecular 
weight heparin, even though the Toluidine Blue assay showed that this material had the 
lowest level of exposed sulfate groups.
Thrombin bound to all these membranes could be partially released by incubation in 
buffer of high ionic strength (Table 4.18).
PPy/heparin deposited on RVC also bound thrombin (Table 4.19) and this was 
partially released by a high salt wash. The amount of thrombin bound was shown to be 
linear with respect to incorporated heparin (Figure 4.12). Again, PPy containing heparin 
of low molecular weight on RVC gave the highest level of thrombin incorporation.
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Thrombin binding to PPy/heparin was improved by application of a negative
potential (Table 4.23).
Chapter 5 M odification o f PPy/heparin membranes
and the effects on thrombin binding
166
CHAPTER 5 MODIFICATION OF PPY/HEPARIN MEMBRANES AND THE 
EFFECTS ON THROMBIN BINDING
5.1 INTRODUCTION
Incorporation of heparin into polypyrrole membranes is essentially by 
entanglement. This leads to the possibility that substantial parts of the heparin chain 
could be quite distant from the membrane surface and therefore largely unaffected by 
changes in the charge of the membrane. Protein molecules bound to these more distant 
parts of the heparin chain might then not be amenable to electrochemical release from 
the complex. Treatment with heparin degrading enzymes should remove the more 
distant part of the heparin chains and may thus make the electrochemical release of 
bound thrombin easier.
In this chapter, the action of two enzymes was evaluated. These were 
heparinase, which depolymerised the heparin chain, and sulfatase, which should 
hydrolytically remove sulfate groups from the chain. Also evaluated was chemical 
reduction with sodium dithionite as an alternative method to change self-charge on the
membrane.
Heparin can be depolymerized enzymatically. Heparinase acts on heparin by 
breaking the glycosidic linkages between hexosamin and uronic acid [114] as shown in
Figure 5.1. Heparinase has been used to prepare commercial low  molecular weight 
heparins.
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Figure 5.1 Scheme o f heparinase cleavage o f heparin [114]. X  = SO/ or H, and Y = 
SO3 or COCHs.
Chondro-6-sulfatase was also used in this work. The function o f  this enzyme is 
to  carry out the desulfation o f  the disaccharide 6-sulfates, and to catalyse the liberation 
o f  inorganic sulfate [115,116].
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5.2 EXPERIMENTAL
5.2.1 Chemicals and Materials
Heparinase I from Flavobacterium heparinum (H 2519), chondro-6-sulfatase 
from proteus vulgaris (C 3030) and sodium dithionite were all from Sigma. The 
sources of all other reagents have been described previously.
5.2.2 Preparation of PPy/heparin membranes
Both “one-sided” and “double-sided” PPy membranes were electrochemically 
deposited onto Pt/PVDF/Pt matrix as described in Section 2.1. The polymerisation 
conditions for each PPy membrane are shown in Table 5.1
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Table 5.1 Polymerisation conditions for preparation o f PPy membranes.
PPy membrane Polymerisation conditions
PPy/Hep,
one-sided
0.5% unfractionated heparin + 0.1 M pyrrole, 




0.05 M pTSNa + 0.2 M pyrrole, galvanostatic 
polymerisation with 0.5 mA cm"2 for 4 minutes
Hep/Hep
double-sided
0.01% unfractionated heparin + 0.1 M pyrrole, 




0.01% heparin (Mwt: 6000) + 0.1 M pyrrole, 




0.01% heparin (Mwt: 3000) + 0.1 M pyrrole, 




0.05 M pTSNa + 0.2 M pyrrole, galvanostatic 
polymerisation with 0.5 mA cm"2 for 8 minutes
pTS/Hep
(PPy/pTS was grown on one 
side o f Pt/PVDF/Pt, and 
PPy/Hep was grown on the 
other side o f Pt/PVDF/Pt)
0.05 M pTSNa + 0.2 M pyrrole, galvanostatic 
polymerisation with 0.5 mA cm'2 for 8 minutes; 
0.01% unfractionated heparin + 0.1 M pyrrole, 
galvanostatic polymerisation with 0.5 mA cm"2 for 8 
minutes
Notes. The area o f the PPy membrane was 16 cm2.
5.2.3 Modifications of PPy/Heparin Membranes
5.2.3.1 Modification of PPy/heparin membranes with heparinase
A stock solution of heparinase was prepared by dissolving it in 0.1 M sodium 
acetate (pH 7.0) to give an enzyme concentration of 50 units/ml [117, 118].
Modification of both single-sided and double-sided PPy membranes was carried 
out using the same technique. The membranes used were: single-sided PPy/pTS and 
PPy/Hep; double-sided Hep/Hep. These were cut into squares of 0.5 cm x 0.5 cm or 
0.4 cm x 0.4 cm and treated in groups of 25 squares.
To each group was added 250 pi sodium acetate buffer, 30 pi 0.01 M calcium 
acetate and 20 pi heparinase solution. They were then incubated at either 25 °C or 37 
°C.
5.2.3.2 Modification of PPy/heparin membranes with sulfatase
The activity of chondro-6-sulfatase is enhanced by the presence of the acetate ion 
[119], so a stock solution of this enzyme was made up dissolving 2.3 mg sulfatase in 
1.0 ml 0.02 M Tris-HCl (pH 7.5) containing 0.06 M sodium acetate [115,120]. This
gave a solution with 0.345 unit/ml.
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The membranes used in this experiment were: single-sided. PPy/Hep and double­
sided: pTS/pTS, pTS/Hep, Hep/Hep. These were used in batches of 40 squares, each
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5.2.6 Thrombin Binding Experiments with Modified PPy/Heparin Membranes
Thrombin binding with the modified PPy/heparin membranes was studied using 
the procedures described in Section 4.2.10. The binding solution used for each 
experiment was 1 ml 0.3 mg/ml thrombin in Milli-Q water.
5.3 RESULTS AND DISCUSSION
5.3.1 Membrane Modification and Preliminary Characterisations
The Toluidine Blue assay for heparin was carried out on the PPy membranes 
before and after modification. The heparin assay on heparinase modified single-sided 
PPy/Hep membrane (Table 5.2) showed that the absorbance at 631 nm increased 
slightly indicating a reduction in the number of sulfated groups, while the heparin assay 
on the control membrane, PPy/pTS, showed little change. On heparinase modified 
“double-sided” Hep/Hep membrane, the heparin assay showed similar results (Table 
5.3), the absorbance at 631 nm also increased a small amount after modification by 
heparinase.
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Table 5.2 Toluidine Blue assay for heparin in PPy membranes before and after
heparinase modification.
Sample Duration of OD(53i nm
“single-sided” incubation in
25 squares of 0.5 cm heparinase After modification
x 0.5 cm size
PPy/Hep Ohr 0.06
PPy/Hep 0.5 hr 0.07
PPy/Hep 1 hr 0.08
PPy/Hep 2 hrs 0.09
PPy/pTS 0 hr 0.12
PPy/pTS 0.5 hr 0.11
PPy/pTS 1 hr 0.11
PPy/pTS 2 hrs 0.12
Notes. The treatment with heparinase was carried out at room temperature.
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Table 5.3 Toluidine Blue assay fo r heparin on double-sided Hep/Hep before and after 
heparinase modification.
Sample Duration of OD631nm
“double-sided” incubation in
25 aquares o f 0.4 cm heparinase After modification
x 0.4 cm size
Hep/Hep Ohr 0.13
Hep/Hep 2 hrs 0.14
Hep/Hep 15 hrs 0.13
Hep/Hep 21 hrs 0.17
Notes. The treatment with heparinase was carried out at room temperature.
The Toluidine Blue assay of PPy membranes was also carried out before and 
after modification with sulfatase. However, no significant difference could be detected 
(result not shown). Sodium dithionite modified membranes (Table 5.4) seemed to give 
artificially high values for the heparin content of the membranes; these values were 
higher after treatment than before. Perhaps the reduction of PPy+ to PPy0 leads to 
greater access of the Toluidine Blue molecules to the sulfonate groups of heparin.
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Table 5.4 Toluidine Blue assay results for PPy membrane before and after treatment 
with sodium dithionite at room temperature.
Sample 01̂ 631 nm 0®631 nm





Notes. Each sample consisted o f 40 squares o f 0.4 cm x 0.4 cm.
5.3.2 Thrombin Binding with Heparinase Modified PPy/Heparin Membranes
5.3.2.1 Thrombin Binding with Heparinase modified “one-sided” PPy/Heparin 
Membranes
The results of thrombin binding experiments using heparinase-modified 
membranes are shown in Table 5.5 and Table 5.6. Though the results are somewhat 
inconsistent, it is clear that heparinase treatment enhances the thrombin binding capacity 
of heparin containing membranes. The Toluidine Blue assay showed that heparinase 
treatment reduced the heparin content of the membranes so this result is unexpected. 
However, it is consistent with earlier results showing that there was higher thrombin 
binding on membranes containing heparin than those without heparin (PPy/pTS).
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Table 5.5 Thrombin binding results on the PPy membranes before and after
heparinase treatment.
Sample Duration of Thrombin binding
Single-sided incubation in 3 hrs
25 squares o f 0.5 cm x 0.5 cm heparinase O D 4 1 0  nm
PPy/Hep Ohr 0.03
PPy/Hep 0.5 hr 0.11
PPy/Hep 1 hr 0.02
PPy/Hep 2 hrs 0.07
PPy/pTS Ohr 0.02
PPy/pTS 0.5 hr 0.01
PPy/pTS 1 hr 0.02
PPy/pTS 2 hrs 0.02
Notes. The modification was carried out at room temperature.
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U D 410 nm
PPy/Hep Ohr 0.07 0.04
PPy/Hep 1 hr 0.08 0.05
PPy/Hep 4 hrs 0.06 0.08
Notes. The modification was carried out at room temperature.
5.3.2.2 Thrombin Binding with Heparinase modified “double-sided” PPy/Heparin 
Membranes
The results of thrombin binding experiments on heparinase-treated double-sided 
PPy/Hep membranes are shown in Table 5.7. Unlike the case with single-sided 
membranes, the binding capacity of thrombin on treated double-sided membranes 
decreased with heparinase treatment. This result is more in line with expectations.
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Table 5.7 Thrombin binding results on “double-sided” Hep/Hep membranes with
heparinase modification at 37 °C.
Sample
Double-sided







O D 4 1 0  nm
Hep/Hep Ohr 0.05
Hep/Hep 1 hr 0.04
Hep/Hep 2 hrs 0.03
Hep/Hep 5 hrs 0.03
Hep/pTS 16 hrs 0.02
5.3.3 Thrombin Binding with Sulfatase Modified PPy/Heparin Membranes
The results of these experiments are shown in Table 5.8. These show that for all 
membranes the binding was increased slightly by sulfatase treatment.
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Table 5.7 Thrombin binding results before and after sulfatase treatment.
Sample
D o u b le - s id e d
Thrombin binding Thrombin binding
(2 hrs)
4 0  s q u a r e s  o f  0 .4  cm  x  0 .4  cm
without sulfatase
OD4 1 0  nm>
with sulfatase (18 hrs)
OD 4 1 0  nm,
pTS/pTS 0.02 0.03
pTS/Hep 0.03 0.04
PPy/Hep * 0.07 0.08
Hep/Hep 0.06 0.10
Notes. All the membranes were synthesised as shown in Table 5.1. *: single-sided 
membrane.
5.3.4 Thrombin Binding with Reductant Modified PPy/Heparin Membranes
Oxidised polypyrrole should be reduced by a chemical reductant such as sodium 
dithionite as shown in Figure 5.2.
(oxidised) (reduced)
Figure 5.2 Scheme o f polypyrrole reduction by chemical reductant. n = a+b; A is an 
anion incorporated into the polypyrrole structure; X" is a cation incorporated into 
polypyrrole structure to compensate the negative charges.
Thrombin binding to all membranes was also increased by treatment with the 
reductant sodium dithionite (Table 5.8). This occurred for both control membranes, 
pTS/pTS, and for heparin-containing membranes, despite the fact that the heparin 
content of these did not change significantly by this treatment (Table 5.4). The increase 
in thrombin binding may be due to the overall decrease in positive charge of the 
membranes after reduction.
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Table 5.8 Thrombin binding results with and without reduction o f the membrane.
Sample Thrombin binding Thrombin binding
(2 hrs) (2 hrs)
Double-sided without reductant with reductant
40 squares o f 0.4 cm x 0.4 cm OD410 nm OD4.IO nm
pTS/pTS 0.02 0.05
pTS/Hep 0.02 0.05




.  m i l  r t  <0 . • 1  •Notes. All the membranes were synthesised as shown in Table 5.1. *. single-sided
membrane.
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5.4 CONCLUSION
The polymeric carbohydrate heparin, can be readily incorporated into PPy 
membranes during electrochemical polymerisation. The resulting composite membranes 
have been shown to specifically bind thrombin (see Chapter 4). However, those parts 
of the heparin molecule that distant from the membrane surface will be least affected by 
changes in the charge of the membranes so that such charges may not lead to release of 
bound thrombin molecules. These same distal section of the bound heparin molecules 
should, however, be most susceptible to modification by enzymes.
In this chapter, experiments with the enzymes, heparinase and sulfatase are 
described; these experiments were aimed at modifying the PPy incorporated heparin 
with the intention of modifying the thrombin binding properties of these membranes.
Incubation with heparinase removed a significant amount of heparin as shown by 
the Toluidine Blue assay (Table 5.2, 5.3) though incubation with sulfatase produced 
little apparent change in the number of sulfate groups in the composite membrane. 
Double-sided membranes treated with heparinase showed reduced binding of thrombin 
as expected (Table 5.7), however, the same treatment with single-sided membranes led 
to increased binding (Table 5.5, 5.6). Presumably the heparinase treatment somehow 
affected the previously observed non-specific binding to these membranes. A similar 
increase in thrombin binding was observed for the sulfatase-treated membranes despite 
the fact that little change in the Toluidine Blue assay results was observed.
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CHAPTER 6 PRELIMINARY STUDY ON PPY/PMAS COMPOSITE 
MEMBRANES
6.1 INTRODUCTION
Sulfonated polyaniline (SPAN) is a self-doped water soluble conductive 
polyaniline derivative [121-123], Poly(aniline sulfonic acid) is attractive due to its 
unique electroactive properties, good water solubility, and wide variety of potential 
industrial applications [121]. The chemical structure of Poly(aniline sulfonic acid) is 
shown in Figure 6.1.
ho3s ho3s ho3s ho3s
Figure 6.1 The chemical structure o f Poly (aniline sulfonic acid). R= -H or -OCH3
As described in Chapter 1, counteranions from simple anions to 
polyelectrolytes can be incorporated into polypyrrole structures during electrochemical
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oxidation. In this chapter, an electroactive conducting polyelectrolyte (poly(2- 
Methoxyaniline-5-sulfonic acid), PMAS) was investigated for use as the dopant to be 
incorporated into polypyrrole. Based on the high level of sulfonate residues contained 
in this new polypyrrole-PMAS composite, thrombin binding and release to this 
composite membrane was studied.
6.2 EXPERIMENTAL
6.2.1 Chemicals and Materials
Poly(2-Methoxyaniline-5-sulfonic acid), PMAS, was obtained from NITTO 
Chemical Industry Co., LTD. The sources of all other reagents have been stated 
previously.
6.2.2 Preparation of Polypyrrole-PMAS Composite Membrane
6.2.2.1 PPy/PMAS composite membrane grown on platinised PVDF substrate
The PPy/PMAS composite membranes were electrochemically synthesised as 
described in Section 2.2.1. The polymerisation conditions for each composite 
membrane are shown in Table 6.1.
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PPy/PMAS-1 0.2 M pyrrole + 0.5% PMAS, galvanostatic polymerisation 
with 0.5 mA cm ~2 for 30 minutes.
PPy/PMAS-2 0.2 M pyrrole + 0.5% PMAS, galvanostatic polymerisation 
with 0.5 mA cm'2 for 8 minutes.
PPy/PMAS-3 0.2 M pyrrole + 0.5% PMAS, galvanostatic polymerisation 
with 0.5 mA cm'2 for 1 hr.
PPy/PMAS-4 0.2 M pyrrole + 0.1% PMAS, galvanostatic polymerisation 
with 1 mA cm'2 for 4 hrs.
6.2.2.2 PPy/PMAS composite deposited on RVC substrate
The polymerisation cell used was the three-electrode cell described in Section 
2.2.2. The polymerisation solution containing 0.5% PMAS in 0.2 M pyrrole with 
constant current of 4, 8, 16 or 32 mA applied for 2, 4, 8 or 32 minutes was employed 
(Table 6.2).
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PPy/PMAS/RVC-l 0.2 M pyrrole + 0.5% PMAS, galvanostatic polymerisation 
with 8 mA for 8 minutes.
PPy/PMAS/RVC-2 0.2 M pyrrole + 0.5% PMAS, galvanostatic polymerisation 
with 4 mA cm’2 for 32 minutes.
PPy/PMAS/RVC-3 0.2 M pyrrole + 0.5% PMAS, galvanostatic polymerisation 
with 16 mA for 4 minutes.
PPy/PMAS/RVC-4 0.2 M pyrrole + 0.1% PMAS, galvanostatic polymerisation 
with 32 mA for 2 minutes.
6.2.3 Cyclic Voltammetry (CV)
The PPy/PMAS film was grown on a Pt disk in 0.2 M pyrrole and 0.5% PMAS 
with constant current of 0.5 mA for 1 minute. The electroactive redox properties of this 
film were characterised by cyclic voltammetry as described in Section 2.6.
6.2.4 X-Ray Photoelectron Spectroscopy (XPS)
The elements, C, O, S, N, on the surface of PPy/PMAS films were determined by 
XPS as described in Section 2.4.
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6.2.5 Toluidine Blue Assay
As there are sulfated groups in the PMAS structure, the Toluidine Blue assay 
was carried out to estimate the level of sulfated groups incorporated. The procedure 
used was the same as that for the heparin assay on the PPy/Hep membranes described in 
Section 2.11.
6.2.6 Thrombin Assay
Thrombin activity was assayed by using the specific substrate, N-p-tosyl-gly-pro- 
arg-p-nitroanilide as described in Section 2.13.
6.2.7 Thrombin Binding and Release to the PPy/PMAS composite membranes
Thrombin binding and release to the PPy/PMAS composite membranes were 
studied using the same procedure as described in Section 4.2.10.
6.3 RESULTS AND DISCUSSION
6.3.1 Membrane Synthesis and Preliminary Characterisation
6.3.1.1 Membrane synthesis on platinised PVDF substrate
Similar to the incorporation of other counterions into the polypyrrole structure 
described previously, PMAS was also readily incorporated during electrochemical
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oxidation. The chemical structure of PMAS and its incorporation to polypyrrole are 
shown in Figure 6.2.
Figure 6.2 The chemical structure o f Poly (2-Methoxyani line-5-sulfonic acid), PMAS, 
and the scheme for its incorporation into polypyrrole during electrochemical 
polymerisation [124].
As other workers have reported [124], these PPy/PMAS membranes can be 
synthesised with very low potential, such as 0.4 V ~ 0.5 V vs Ag/AgCl. Also 
interestingly, the grown PPy/PMAS membranes are quite thick, and their thickness 
increases with increase in growth time. In addition, the membrane could be entirely 
removed from the Pt/PVDF/Pt substrate. After drying, the membrane became thinner 
and shrunk, which indicated that the PPy/PMAS was of high water content, also the 
shrunk membrane can not re-hydrate. However, the membrane retains its thickness 
when it is kept wet in water.
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The XPS results on PPy/PMAS membranes are shown in Table 6.3. The results 
show that PMAS was incorporated with high ratio into the polypyrrole structure.
Table 6.3 XPS results fo r  PPy/PM AS membranes.
Polymerisation conditions o% C% S% N% Py/MAS 
(mole ratio)
0.2 MPy + 0.5% PMAS, 
galvanostatic polymerisation with 1 
mA cm'2 for 4 hrs
25.56 62.70 3.88 7.86 1.03
0.2 MPy + 0.5% PMAS, 
galvanostatic polymerisation with 0.5 
mA cm'2 for 1 hr
21.13 66.31 5.13 7.43 0.45
0.2 MPy + 0.5% PMAS, 
galvanostatic polymerisation with 0.5 
mA cm'2 for 8 minutes
24.65 62.11 4.09 9.15 0.24
Notes. % refers to the atomic conc%.
Table 6.4 shows the Toluidine Blue assay results on the PPy/PMAS membranes 
made with different polymerisation conditions and different sizes. The membranes were 
prepared as described in Table 6.1. The absorbance at 631 nm decreased with the size 
of PPy/PMAS membrane used showing that the presence of sulfate groups could be 
determined using Toluidine Blue. Comparison with data from a native heparin assay 
shows that the sulfate groups on a rectangle, 1 cm x 3 cm, of PPy/PMAS membrane 
were approximately equal to those of 10 ~ 25 pg heparin, and this should result in a
higher thrombin binding capacity.
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Table 6,4 Toluidine Blue assay results on PPy/PM AS membranes.
Sample Size O D ò31 nm
cm x cm







0 Hg heparin 0.31
10 pg heparin 0.25
25 pg heparin 0.11
Notes. The assay fo r  native heparin served as control.
6.3.1.2 Polymer synthesis on RVC substrate
PPy/PMAS was readily grown on an RVC substrate. However, the same 
problem as encountered in Section 3.3.1.2 for the PPy/heparin system was encountered 
here in that the polymer did not grow through the RVC structure but grew only on the 
surface. Furthermore, with extended growth time, some “drop-like” particles deposited 
on the surface, and these were very easy to peel off (Figure 6.3).













Figure 6.3 Schematic diagram o f PPy/PMAS/RVC.
6.3.1.3 Cyclic Voltammetry, CV
Cyclic voltammogram (Figure 6.4) of PPy/PMAS membrane shows that there are 
oxidation and reduction responses. So these composite membranes were electroactive.
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Potential (Volt) vs Ag/AgCl
Figure 6.4 Cyclic voltammogram o f PPy/PMAS in 0.2 M  NaCl. Potential applied: 
-0.60 V~ +0.70 Vvs Ag/AgCl. Scan rate: 100 m V s 1.
6.3.2 Thrombin Binding and Release to/from the PPy/PMAS Composites
Table 6.5 shows the thrombin binding and release results on PPy/PMAS/RVC 
samples. In this experiment, PPy/PMAS/RVC membranes were prepared as described in 
Table 6.2; PPy/heparin/RVC was used as a control. Thrombin binding on PPy/PMAS 
was greater than on PPy/heparin. However, with buffer TE, the thrombin bound on 
PPy/PMAS was not removed, unlike the case for PPy/Hep where significant amounts 
were removed (see Section 4.3.).
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Table 6,5 Thrombin binding and release on PPy/PMAS/RVC.
Sample Thrombin binding, Thrombin after release
(RVC) (RVC)
5 x 5 x 15 mm







Notes. Control membrane PPy/Hep/RVC was grown in 0.1 % heparin with 0 .1  M  
pyrrole and with constant current o f 8 mA applied for 16 minutes. All RVC samples 
were incubated in 0.5 mg/ml BSA in 0.01 M  tris buffer (pH 7.4) for 2 hrs; then 
incubated in 0.3 mg/ml thrombin in water for 3 hrs. After that, they were washed with 
buffer TW for 1 hr. Each RVC sample was cut into half one for thrombin assay 
(binding), the other was incubated in buffer TE for 1  hr, then for thrombin assay. ND 
= not done.
Chapter 6 Preliminary study on PPy/PMAS membranes with protein separation
6.3.3 UV-Spectrum Study on PPy/PMAS Stability in Aqueous Solution
During the thrombin binding and release experiments (Section 6.3.2), the 
observation was made that a light brown colour leached from the membrane during the 
experiment with all aqueous solutions (buffer TL, TW and TE or even Milli-Q water 
itself). To investigate the stability of PPy/PMAS in aqueous solution, a series of 
PPy/PMAS/Pt/PVDF/Pt membranes were made with various concentrations of PMAS 
and grown under various conditions. After synthesis, the membranes were rinsed with 
distilled water, and then soaked for 2 hrs in 10'3 M NaNC>3 to displace the excess 
PMAS. Following this, the membrane was rinsed thoroughly with Milli-Q water. Each 
PPy/PMAS membrane was then incubated in 10 ml Milli-Q water for various times 
(Table 6.6), then an aliquot of 1 ml supernatant was removed and assayed by UV- 
spectrum (Figure 6.5).
Table 6.6 The preparation o f PPy/PMAS membranes.
No PPy membrane Polymerisation conditions Incubation time
Py PMAS (or Current Time in Milli-Q H20
heparin) density
M % mA erri2 minutes day
1 PPy/Hep 0.2 0.05 0.5 30 8
2 PPy/PMAS 0.2 0.05 0.0625 8 8
3 PPy/PMAS 0.2 0.1 0.0625 8 8
4 PPy/PMAS 0.2 0.05 0.0363 60 6
5 PPy/PMAS 0.2 0.05 0.0182 180 6
6 PPy/PMAS 0.4 0.05 0.0182 180 5
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Wavelength (ran)
(b)
Figure 6 .5  Absorption spectra o f supernatant from PPy membrane incubation solution 
(a); absorption spectra o f PMAS and pyrrole in Milli-Q water (b). Refer to Table 6.6 
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Compared with the spectra of PMAS in Milli-Q water and pyrrole in Milli-Q 
water (Figure 6.5.b), the spectrum of the supernatant (Figure 6.5.a) showed that this 
material was neither free pyrrole nor free PMAS. These results show that the rate of 
leaching of this unknown material from the membranes is proportional to the 
concentration of PMAS and pyrrole in the membrane, and is higher when the membrane 
was formed with high current.
6.4 CONCLUSIONS
As an alternative to heparin the heavily charged polyanion PMAS was 
incorporated into PPy membranes to give a composite material potentially able to bind 
thrombin (Figure 6.2). These membranes were readily prepared on both platinised 
PVDF and RVC and were analysed by both XPS and the Toluidine Blue assay (Table 
6.3, 6.4). The results of these assays showed good incorporation of sulfonic acid 
groups, roughly equivalent to that from the previously prepared heparin membranes. 
RVC pieces coated with PPy/PMAS membranes showed good binding capacity for 
thrombin. However, unlike the corresponding heparin containing membranes, thrombin 
was not released by treatment with buffer of high ionic strength (Table 6.5).
Colour leaching from PPy/PMAS during experiments in aqueous solution 
suggested that these membranes are unstable. UV spectra of supernatants from these 
experiments (Figure 6.5) showed that the material leaching out was neither pyrrole itself 
nor PMAS. Its identity still has not been established.
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CHAPTER 7 CONCLUSIONS
The aim of this work was to investigate the use of novel polymers in the 
development of new techniques for protein separation. The specific polymers chosen 
were conducting, electroactive polymers with particular emphasis on polypyrrole. 
Such polymers readily incorporate various ions during electrochemical polymerisation 
and this can be exploited in designing novel media for protein fractionation.
Protein vary in: (i) size, (ii) charge — both nett charge and distribution of charge 
over the protein surface, (iii) hydrophobicity — both overall hydrophobicity and 
distribution of hydrophobic amino acid residues, (iv) glycosylation and other post­
translational modifications and (v) biological activity and biologically specific 
interactions. All these attributes have been exploited in developing techniques for 
separation of proteins; typically protein purification schemes utilize a combination of 
these techniques.
Most protein separation techniques other than those based on size rely on 
differential binding and/or release from a specific solid support. Thus charge-based 
separations (ion exchange chromatography) utilize changes in ionic strength or pH to
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effect protein binding and release while hydrophobic interaction chromatography can 
use either changes in ionic strength or the use of organic solvents to modify binding.
In developing techniques based on conductive, electroactive polymers 
consideration is given to the fact that the charge on the composite can be readily 
changed by a simple change to the applied potential. Such a change may well prove 
to be useful in releasing a bound protein by weakening ionic interactions and, in this 
respect, is analogous to a change in ionic strength.
It has long been known that the protein BSA binds readily to the dye Cibacron 
Blue and this interaction is often used to remove serum albumin from admixture with 
other proteins by adsorption to Cibacron Blue immobilised on various matrices. The 
bound BSA can then be recovered, if required, by elution with buffer of high ionic 
strength.
ppy membranes incorporating Cibacron Blue (PPy/CB) or its conjugate with 
dextran, Blue Dextran (PPy/BD), were prepared by electrochemical polymerisation of 
pyrrole in the presence of these dyes. These membranes were evaluated for their 
ability to reversibly bind BSA. The behaviour of BSA with these membranes was 
compared with that of the protein ovalbumin (OVA) which had previously been shown 
not to bind to the affinity adsorbent, CB-agarose. Preliminary experiments using PPy 
membranes grown on platinised PVDF showed that both BSA and OVA bound to the 
membrane PPy/BD but also to a control membrane, PPy/pTS. However, for each 
membrane OVA bound more strongly than BSA. A partial explanation for this was 
found when experiments showed that the platinised surface of the PVDF disk was
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responsible for much of this binding and not the PPy surface.’ Pre-treatment of the 
membrane with a solution of a non-specific protein, casein, reduced most the BSA 
binding to all membranes tested but only slightly reduced the binding of OVA.
This series of membranes exhibited a high capacity for binding of both BSA and 
OVA with little evidence of binding influenced by specific interaction between BSA 
and Cibacron Blue. The only evidence obtained for this interaction was found in a 
series of release experiments in which the release of BSA into high salt buffer from 
dye containing membranes was found to be higher than from control membranes.
In order to avoid effects due to the platinised PVDF surface, PPy membranes 
containing the two dyes were prepared on stainless steel surfaces, on RVC and also as 
free standing membranes. For each of these systems the binding of the two proteins 
(BSA and OVA) was much less than on the PPy/Pt/PVDF membranes initially tested, 
but again there was little evidence of binding influenced by the dye-BSA interaction.
An indication of interaction between BSA and a dye-incorporating membrane 
was obtained during transport experiments when it was found that the membrane 
PPy/CB both bound significant amounts of BSA and allowed transport of this protein.
The important proteolytic enzyme, thrombin, can be purified by affinity 
chromatography on heparin linked to various solid supports. The interaction is 
essentially charge-based and elution from these affinity matrices is by high salt buffers. 
It is envisaged that an analogous system using PPy membranes incorporating heparin
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could be developed and might lead to a useful and economic technique for thrombin 
purification.
PPy membranes incorporating heparin were readily prepared and were 
characterised by XPS and chemical assay. Initial enzyme binding experiments were 
carried out using trypsin as a model rather than thrombin in order to reduce costs. 
Non-specific binding to the PPy/heparin membranes was again seen, but after pre­
incubation with BSA solution this was almost eliminated to reveal binding mediated 
by the specific trypsin-heparin interaction. Incubation with a high salt buffer led to the 
release of most, but not all of the bound trypsin. Similarly, bound trypsin could be 
released electrochemically as shown by experiments carried out in the transport cell 
though the results of these experiments can not be used to give a quantitative estimate 
of the extent of release.
Thrombin also was shown to bind to PPy/heparin membranes, both on platinised 
PVDF and on RVC. The extent of binding was shown to be linear with the amount of 
heparin incorporated in the membrane. A high salt wash was shown to release some of 
the bound thrombin though the extent of release was quite variable possibly due to a 
non-specific component of the binding. In preliminary experiments, thrombin binding 
to PPy/Hep/RVC was shown to be increased by the application of a low negative 
potential. However, when this potential was reversed, no subsequent release of
thrombin could be detected.
Heparin is a sulfated, polymeric carbohydrate and on incorporation into 
polypyrrole, substantial parts of the carbohydrate chain may extend significant
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distances from the membrane surface. It would be expected that these parts of the 
heparin molecule would interact readily with thrombin or trypsin. This interaction 
would be minimised in buffers of high ionic strength, thereby allowing the bound 
enzyme to be released. However, changes to the charge of the electroactive membrane 
may not be felt at the more distant parts of the heparin molecule so that 
electrochemical release of all the bound enzyme might not be possible. A potential 
way to resolve this difficulty would be to remove the distal parts of the heparin 
molecule enzymetically before thrombin binding.
The action of two different heparin-modifying enzymes was evaluated. These 
were heparinase which acts to depolymerize the heparin chain and sulfatase which will 
hydrolyse sulfate groups from the carbohydrate chain. Treatment of PPy/heparin 
membranes with heparinase led to a reduction in the total heparin content of the 
membrane as shown by the chemical assay. Sulfatase treatment appeared to give little 
reduction in the assay results for membrane-incorporated sulfate.
The overall thrombin binding capacity of “single-sided” PPy/heparin membranes 
increased slightly after heparinase treatment while that of “double-sided” membranes 
decreased. The result for single-sided membranes in somewhat unexpected and may 
be a reflection of some effect of the platinised surface. Sulfatase treatment appeared to 
give an increase in thrombin binding despite there being no apparent change in the 
sulfate analysis of the treated membrane. This result is difficult to explain.
As an alternative to the incorporation of heparin into PPy membranes a synthetic 
polyelectrolyte, poly(2-methxyaniline-5-sulfonic acid) (PMAS), was incorporated. It
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was readily incorporated into PPy membranes as shown by XPS and chemical 
analysis.
Such membranes grown on an RVC substrate, readily bound thrombin; however 
when incubated with the high salt buffer, little of the bound thrombin was released. 
These membranes appeared to be unstable in aqueous solution so this approach was 
not pursued further.
The first system evaluated, which involved binding of the model proteins BSA 
and OVA to PPy membranes incorporating specific dyes, gave unexpected results due 
to the strong binding of both proteins to the membranes tested. There was little 
evidence of selective binding of BSA to dye-containing membranes. The forces 
directing this non-specific binding must involve the PPy background of the composite 
membrane.
A more promising approach was the use of PPy/heparin membranes to bind the 
enzymes trypsin and thrombin. In this case specific binding was found for both 
enzymes and treatment with high ionic strength buffers gave good release. Some 
evidence was obtained for an electrochemically driven binding and release but more 
work is needed before a satisfactory system for purification of these enzymes is
achieved.
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